{
    "testId": 376635437,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 26,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 29,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 4,
    "incorrectToIncorrect": 3,
    "timeInSeconds": 1832,
    "averageTimeSpentInSeconds": 134,
    "otherAverageTimeSpentInSeconds": 58,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 2552,
            "questionIndex": 2552,
            "questionText": "<p>A 35-year-old woman comes to the office for her first prenatal visit.&nbsp; The patient has been married for 8 years and has tried to conceive for the past 3 years.&nbsp; For the past few weeks, she has experienced morning sickness and has had abdominal distension and breast fullness.&nbsp; Her last menstrual period was 2 months ago, and she reports a positive home pregnancy test 2 weeks ago.&nbsp; The patient has no chronic medical conditions or prior surgeries.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 72/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows a soft, nontender, tympanic abdomen with no masses.&nbsp; Bedside ultrasound examination reveals a thin endometrial stripe.&nbsp; Two office urine pregnancy tests are negative.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient most likely has <strong>pseudocyesis</strong>, a persistent nondelusional belief of being pregnant in a nonpregnant patient.&nbsp; Patients commonly experience <strong>symptoms of early pregnancy</strong> such as amenorrhea, morning sickness, and abdominal distension, but <strong>evaluation excludes pregnancy</strong> (eg, negative results on office urine pregnancy tests, thin endometrial stripe on ultrasound).</p><p>Pseudocyesis can occur when <strong>psychological pressures</strong> (eg, difficulty conceiving, as in this patient), social pressures, and the <strong>somatization of stress</strong> affect the hypothalamic-pituitary-ovarian axis, or when bodily changes (eg, weight gain, amenorrhea) are misinterpreted by the patient.&nbsp; The end result is a <strong>deeply held, nondelusional belief of being pregnant</strong> that may be strong enough to cause a patient to misread a negative home pregnancy test result as positive.&nbsp; Because pseudocyesis is a form of somatization, management requires psychiatric evaluation and treatment.</p><p><strong>(Choice A)</strong>&nbsp; Despite the patient&#39;s report of a positive home pregnancy test, the 2 negative office urine pregnancy tests and a thin endometrial stripe seen on ultrasound examination exclude the possibility of an early intrauterine pregnancy.</p><p><strong>(Choice B)</strong>&nbsp; An ectopic pregnancy can present with a positive home pregnancy test and an empty uterine cavity (ie, thin endometrial stripe on ultrasound).&nbsp; However, patients typically have an adnexal mass and a positive pregnancy test in the office.</p><p><strong>(Choice C)</strong>&nbsp; A hydatidiform mole can cause a markedly elevated &#946;-hCG level and abdominal distension (ie, uterine size greater than dates).&nbsp; However, ultrasound examination typically reveals an intrauterine, heterogeneous cystic mass consistent with excessive trophoblastic tissue.</p><p><strong>(Choice D)</strong>&nbsp; Following resolution of a <a href=\"58053\">complete spontaneous abortion (SAB)</a>, office testing (eg, urine pregnancy test, ultrasound examination) may be negative for pregnancy.&nbsp; In contrast, patients with a <a href=\"35747\">missed SAB</a> typically have a positive pregnancy test and an ultrasound revealing a nonviable intrauterine gestation.&nbsp; In addition, those with missed SABs usually stop having pregnancy symptoms (eg, morning sickness), unlike this patient.</p><p><strong>(Choice E)</strong>&nbsp; Premenstrual syndrome (PMS) is associated with regular ovulatory menstrual cycles rather than amenorrhea.&nbsp; PMS can present with bloating, breast tenderness, and affective symptoms (eg, labile mood) but is not associated with the belief of being pregnant.</p><p><strong>Educational objective:</strong><br>Pseudocyesis is a persistent, nondelusional belief of being pregnant in a nonpregnant patient.&nbsp; A patient with pseudocyesis can have symptoms of early pregnancy (eg, morning sickness, abdominal distension), but pregnancy testing is negative and ultrasound examination reveals an empty uterus (eg, thin endometrial stripe).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24274,
            "topic": "Pseudocyesis",
            "titleId": 24274,
            "title": "Pseudocyesis",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Early intrauterine pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 3,
                    "correctTaken": 313,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Missed abortion",
                    "choiceNumber": 4,
                    "correctTaken": 4644,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premenstrual syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pseudocyesis",
                    "choiceNumber": 6,
                    "correctTaken": 10419,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1820,2183,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29662961",
                    "mediaDataId": 0,
                    "title": "Biopsychosocial view to pseudocyesis: a narrative review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29662961",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23672289",
                    "mediaDataId": 0,
                    "title": "Endocrinology and physiology of pseudocyesis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23672289",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16538,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1097,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 3190,
            "questionIndex": 3190,
            "questionText": "<p>A 17-year-old boy is brought to the emergency department by his parents due to a recent change in behavior.&nbsp; The patient was previously polite and soft-spoken, but he has become intermittently irritable, impatient, and rude over the past few weeks.&nbsp; His parents initially dismissed his new behavior as a &#x22;phase&#x22;; however, they grew more concerned last night when they discovered that he had stolen money from their wallets and later found him pacing in his room at 4:00 AM.&nbsp; When questioned by his father about his strange behavior, the patient said, &#x22;I have to be careful because I&#39;m being followed by CIA agents.&#x22;&nbsp; He has no medical conditions.&nbsp; His father has chronic pain and insomnia, for which he takes oxycodone and diphenhydramine.&nbsp; Temperature is 36.6 C (97.9 F), blood pressure is 164/98 mm Hg, pulse is 124/min, and respirations are 18/min.&nbsp; On physical examination, the patient appears fearful.&nbsp; He is sweating profusely and his pupils are dilated.&nbsp; He is observed in the emergency department for several hours, his condition improves, and he is discharged to the care of his parents.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s episodic <strong>agitation</strong>, insomnia, <strong>psychosis</strong> (eg, delusions about the CIA), change in behavior (eg, stealing money), and signs of <strong>sympathetic hyperactivity</strong> (eg, mydriasis, tachycardia, hypertension, diaphoresis) with subsequent return to baseline functioning following an observed period of abstinence are consistent with <strong>amphetamine intoxication</strong>.&nbsp; Potential serious complications of amphetamine intoxication include cardiac arrhythmias, seizures, hyperthermia, and intracerebral hemorrhage.</p><p>The diagnosis of amphetamine intoxication is clinical.&nbsp; A positive toxicology screen can be supportive.&nbsp; However, the decongestant pseudoephedrine and the antidepressants bupropion and selegiline can cause false positives for amphetamines on urine toxicology testing.&nbsp; Amphetamines include a range of substances, from those prescribed for the treatment of attention-deficit hyperactivity disorders to the newer synthetic cathinones (ie, bath salts), which are not detectable on routine toxicology screens.</p><p><strong>(Choice B)</strong>&nbsp; Some symptoms of anticholinergic poisoning (eg, mydriasis, hyperthermia, tachycardia) can occur due to amphetamine intoxication.&nbsp; Anticholinergic poisoning is differentiated by the presence of dry skin and mucous membranes, motor symptoms (eg, myoclonic jerks, tremors), and other classic anticholinergic manifestations such as ileus and urinary retention.&nbsp; Delirium is more likely than isolated psychotic symptoms.</p><p><strong>(Choice C)</strong>&nbsp; A manic episode of bipolar disorder is characterized by at least a week of elevated/irritable mood, increased energy, decreased need for sleep, and pressured speech; it may also include psychotic features.&nbsp; Stimulant intoxication can mimic mania and should be ruled out before concluding that a patient is having a manic episode.&nbsp; A manic episode would not subside quickly without any pharmacologic intervention.</p><p><strong>(Choice D)</strong>&nbsp; Diagnosis of primary psychotic disorders requires ruling out substance-induced causes.&nbsp; Brief psychotic disorder is characterized by acute onset of one or more psychotic symptoms lasting &#8805;1 day but &lt;1 month, with eventual complete resolution.&nbsp; Although this patient has psychotic features, his pupillary dilation, tachycardia, diaphoresis, and elevated blood pressure combined with resolution of signs/symptoms during observation support a diagnosis of substance-induced psychosis.</p><p><strong>(Choice E)</strong>&nbsp; Delusional disorder can only be diagnosed if a delusion has been present for &#8805;1 month and does not result from intoxication, as in this patient.</p><p><strong>(Choice F)</strong>&nbsp; Opioid (eg, oxycodone) withdrawal symptoms include muscle spasms, joint pain, nausea and vomiting, diarrhea, abdominal cramps, rhinorrhea, lacrimation, and sweating.&nbsp; Irritability, hypertension, and mydriasis may occur.&nbsp; However, delusions are unlikely, and symptoms of opioid withdrawal often last 3-5 days.</p><p><strong>Educational objective:</strong><br>Amphetamine intoxication can present with psychiatric symptoms, including irritability, agitation, and psychosis.&nbsp; Common physical signs include tachycardia, hypertension, hyperthermia, diaphoresis, and mydriasis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24386,
            "topic": "Stimulants",
            "titleId": 24386,
            "title": "Stimulants",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amphetamine intoxication",
                    "choiceNumber": 1,
                    "correctTaken": 10369,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anticholinergic poisoning",
                    "choiceNumber": 2,
                    "correctTaken": 2328,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 3,
                    "correctTaken": 72,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 485,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delusional disorder",
                    "choiceNumber": 5,
                    "correctTaken": 75,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opioid withdrawal",
                    "choiceNumber": 6,
                    "correctTaken": 3534,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2554,2862,true,-1,1*1180,1320,true,-1,1*388,531,true,-1,1*637,1035,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23827164",
                    "mediaDataId": 0,
                    "title": "Bath salts intoxication: a case series.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23827164",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23757186",
                    "mediaDataId": 0,
                    "title": "Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23757186",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 238,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16863,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1580,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 12350,
            "questionIndex": 13573,
            "questionText": "<p>A 52-year-old man comes to the office for follow-up for chronic back pain.&nbsp; Since starting scheduled-dose hydrocodone-acetaminophen 3 months ago, his pain has not interfered with his work.&nbsp; The patient also takes naproxen as needed and attends tai chi classes twice a week.&nbsp; He has no other medical conditions and takes no other medications.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; A review of the state prescription drug monitoring database shows 60 tablets of hydrocodone-acetaminophen refilled every 30 days and no irregularities.&nbsp; The patient has 3 days of medications left and requests a refill.&nbsp; A urine drug screen is positive for opiates and phencyclidine (PCP).&nbsp; After reviewing the results with the patient, he insists that he uses no recreational drugs, including PCP.&nbsp; Which of the following is the most appropriate response?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Urine drug screening</strong> (UDS) is done routinely in long-term management of patients taking controlled substances (eg, opioids).&nbsp; UDS detects concurrent <strong>recreational drug use</strong>, verifies adherence to treatment (ie, test is positive for the prescribed drug), and identifies possible medication diversion (ie, test is negative despite reported adherence).</p><p>However, an in-office UDS can give <strong>erroneous results</strong> because the immunoassay may cross-react with medications in other classes (ie, false-positives) or may not detect all the drugs (or excreted metabolites) within a class (ie, false-negatives).&nbsp; For example, common over-the-counter medications (eg, dextromethorphan, diphenhydramine, ibuprofen), which patients often forget to disclose, can cause false-positive results for PCP.&nbsp; Therefore, <strong>confirmatory testing</strong> (eg, gas chromatography with mass spectroscopy) should be obtained to verify unexpected results before assuming recreational drug use or addiction that warrants treatment <strong>(Choice E)</strong>.</p><p>If recreational drug use is verified, further discussions should address the need for substance use counseling and rehabilitation.&nbsp; The patient&#39;s care plan may need to be changed (eg, tapering off the controlled substance prescription) to comply with state-specific rules and avoid possible dangerous drug interactions <strong>(Choices B and C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Repeat UDS should be obtained given the possibility of a false-positive, particularly given the lack of irregularities in the prescription drug monitoring program database.&nbsp; In addition, even if recreational drug use is confirmed, physicians are legally prohibited from reporting it to authorities barring exceptional cases (eg, criminal investigations).</p><p><strong>Educational objective:</strong><br>Urine drug screening can be used in patients on long-term opioid therapy to detect recreational drug use, verify adherence to treatment, and identify possible medication diversion.&nbsp; However, false-positive and false-negative results can occur; unexpected results require confirmatory testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24720,
            "topic": "Prescription drug misuse",
            "titleId": 24720,
            "title": "Prescription drug misuse",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Because PCP is an illegal drug, I have to report the test result to the appropriate authorities.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I can&#39;t refill your opioid prescription, but if you develop withdrawal symptoms, we can discuss ways to manage that.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 2574,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I can prescribe only a limited amount of opioid medication to help you taper off.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 2840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I need to obtain an additional urine study today and will call you to discuss the results.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 8134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s okay to be honest with me about drug use; I&#39;ll refer you to an addiction specialist for treatment.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 2803,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1546,1728,true,-1,1*156,377,true,-1,1*636,808,true,-1,1*820,1012,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30600984",
                    "mediaDataId": 0,
                    "title": "Urine drug tests: ordering and interpreting results.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30600984",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 298,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16944,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1034,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4366,
            "questionIndex": 4366,
            "questionText": "<p>A 37-year-old man comes to the emergency department due to severe nausea and vomiting a day after receiving chemotherapy for oropharyngeal cancer.&nbsp; He has no other acute symptoms and is otherwise tolerating his treatments.&nbsp; The patient has a history of bipolar disorder that has been stable, as well as a remote history of alcohol abuse.&nbsp; Medications include lithium and lamotrigine.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 140/86 mm Hg, pulse is 98/min, and respirations are 16/min.&nbsp; Physical examination shows mild erythema at the excision site of the primary lesion on the base of the tongue but is otherwise normal.&nbsp; Laboratory results indicate mild dehydration, lithium level of 0.6 mEq/L (normal: 0.6-1.2 mEq/L), and blood alcohol level of 0.&nbsp; The patient is treated with intravenous normal saline and multiple doses of an antiemetic to stop his vomiting.&nbsp; Several hours later, he has sudden neck pain, his neck muscles are stiff, and he has difficulty speaking.&nbsp; Which of the following medications best explains this patient&#39;s sudden symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is experiencing an <strong>acute dystonia</strong>, an <strong>extrapyramidal symptom (EPS)</strong> that can occur with <strong>dopamine antagonists</strong>, including antiemetics such as <strong>metoclopramide</strong> and prochlorperazine, as well as most antipsychotics.&nbsp; Other EPS types include <strong>parkinsonism</strong> and <strong>akathisia</strong>, both of which can occur after use of a dopamine antagonist such as metoclopramide.</p><p>Acute dystonias can develop within hours to days of initiation of a dopamine antagonist.&nbsp; They are characterized by muscle spasms or stiffness in the head and neck, tongue protrusions, torticollis, and oculogyric crisis (ie, forced, sustained elevation of the eyes in an upward position).&nbsp; Laryngeal dystonias can be life-threatening as they may obstruct the airway.&nbsp; Treatment for a dystonic reaction involves discontinuation of the medication and administration of anticholinergic medications (eg, benztropine) or diphenhydramine, and airway protection if necessary.</p><p><strong>(Choices A, B, and F)</strong>&nbsp; Aprepitant, hydroxyzine, and ondansetron also have antiemetic effects, but they are not dopamine antagonists and do not cause an EPS.&nbsp; Aprepitant is a substance P NK1 receptor antagonist.&nbsp; Hydroxyzine is an antihistamine.&nbsp; Ondansetron is a serotonin 5-HT3 antagonist.</p><p><strong>(Choices C and D)</strong>&nbsp; Lamotrigine (an anticonvulsant) and lithium are used in the treatment of bipolar disorder.&nbsp; Neither is typically associated with an EPS.&nbsp; Lamotrigine is associated with Stevens-Johnson syndrome.&nbsp; Lithium toxicity may cause severe vomiting, but this patient&#39;s lithium level is low.</p><p><strong>Educational objective:</strong><br>The antiemetics metoclopramide and prochlorperazine are dopamine antagonists, which, along with most antipsychotics, can cause extrapyramidal symptoms such as acute dystonias, akathisia, and parkinsonism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 13787,
            "topic": "Dystonia",
            "titleId": 13787,
            "title": "Dystonia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aprepitant",
                    "choiceNumber": 1,
                    "correctTaken": 647,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydroxyzine",
                    "choiceNumber": 2,
                    "correctTaken": 289,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lamotrigine",
                    "choiceNumber": 3,
                    "correctTaken": 806,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 4,
                    "correctTaken": 664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metoclopramide",
                    "choiceNumber": 5,
                    "correctTaken": 9754,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ondansetron",
                    "choiceNumber": 6,
                    "correctTaken": 2783,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "887,955,true,-1,1*676,754,true,-1,1*1167,1198,true,-1,1*854,886,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28061898",
                    "mediaDataId": 0,
                    "title": "Metoclopramide induced acute dystonic reaction:  a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28061898",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26573884",
                    "mediaDataId": 0,
                    "title": "Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26573884",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 14943,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 696,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 10674,
            "questionIndex": 11790,
            "questionText": "<p>A 58-year-old man is brought to the emergency department by his wife for &#x22;unusual behavior.&#x22;&nbsp; She says that since last night, the patient has been afraid to go into their bedroom because he sees &#x22;evil children&#x22; there.&nbsp; He spent most of the night pacing back and forth in the living room and got minimal sleep.&nbsp; Five days ago, when the patient had an asthma exacerbation, his primary care physician added a new oral medication to his regimen.&nbsp; Medical history also includes hypertension and non-insulin-dependent diabetes mellitus.&nbsp; The patient does not drink alcohol but has used marijuana as recently as last week.&nbsp; Vital signs and physical examination are within normal limits.&nbsp; The patient is alert and aware of his surroundings.&nbsp; He reports hearing children laughing at him and frequently covers his ears with his hands.&nbsp; The patient has no suicidal ideation.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient exhibits the acute onset of <strong>psychosis</strong> (hallucinations) that is temporally associated with the introduction of a new medication, most likely high-dose glucocorticoid for his asthma exacerbation.&nbsp; His psychosis does not appear to be associated with delirium (he is alert and oriented) or any other psychiatric or medical illness.</p><p>High-dose glucocorticoids, often given for allergic, inflammatory, or autoimmune conditions, may cause <strong>glucocorticoid-induced psychosis</strong>, an example of <strong>medication-induced psychotic disorder</strong>.&nbsp; Psychotic symptoms typically occur during the first week of glucocorticoid treatment but can occur at any time.&nbsp; Glucocorticoids can also cause manic or depressive symptoms.</p><p><strong>(Choice A)</strong>&nbsp; Brief psychotic disorder is characterized by psychotic symptoms lasting &#8805;1 day but &lt;1 month.&nbsp; This diagnosis is excluded if the symptoms are better explained by the effects of a medication or medical illness.</p><p><strong>(Choice B)</strong>&nbsp; Cannabis (marijuana) use may cause euphoria, perceptual changes, increased appetite, red eyes, slowed reflexes, dizziness, and impaired coordination.&nbsp; Paranoia may occur during acute use but is unlikely to be persistent.</p><p><strong>(Choice C)</strong>&nbsp; The core feature of delirium is fluctuating cognitive impairment, characterized by poor attention and disorientation; psychotic features may be present secondarily.&nbsp; This patient is alert and oriented, making delirium less likely.</p><p><strong>(Choice E)</strong>&nbsp; This diagnosis would be appropriate if the patient&#39;s history, examination, or laboratory results suggested that psychosis was a direct pathophysiological consequence of another medical condition (eg, CNS tumor causing psychosis).</p><p><strong>Educational objective:</strong><br>Medication-induced psychotic disorder is characterized by the acute onset of delusions and/or hallucinations that are temporally associated with the use of a new medication.&nbsp; Glucocorticoids, particularly at high doses, are often implicated in new-onset psychotic symptoms in patients who may have no current underlying psychiatric illness.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 23682,
            "topic": "Substance-induced psychotic disorder",
            "titleId": 23682,
            "title": "Substance-induced psychotic disorder",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 1,
                    "correctTaken": 984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cannabis-induced psychotic disorder",
                    "choiceNumber": 2,
                    "correctTaken": 678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced delirium",
                    "choiceNumber": 3,
                    "correctTaken": 2522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced psychotic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 12615,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychotic disorder due to another medical condition",
                    "choiceNumber": 5,
                    "correctTaken": 133,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "969,1189,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26644319",
                    "mediaDataId": 0,
                    "title": "Sustained corticosteroid-induced mania and psychosis despite cessation: a case study and brief literature review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26644319",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22424158",
                    "mediaDataId": 0,
                    "title": "The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22424158",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 140,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16932,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 335,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 13710,
            "questionIndex": 15100,
            "questionText": "<p>Two days after undergoing a laparoscopic partial colectomy to resect a large adenoma, a 45-year-old woman becomes acutely agitated.&nbsp; She has been anxious and uncooperative since the surgery, but, today, she is repeatedly getting out of bed, shouting &#x22;Get your hands off me!&nbsp; God is watching!&#x22; when the nurses try to redirect her.&nbsp; The patient was given a preoperative dose of intravenous cefoxitin and is receiving IV ketorolac and acetaminophen as needed for pain.&nbsp; Medical history includes polysubstance use and schizoaffective disorder.&nbsp; Chart review shows that she has been prescribed sertraline and a long-acting injection of aripiprazole, but she is unable to provide information about when she had her last dose of either.&nbsp; Temperature is 39 C (102.2 F), blood pressure is 160/90 mm Hg, pulse is 102/min, and respirations are 18/min.&nbsp; The patient is diaphoretic and oriented only to person.&nbsp; Physical examination shows well-healing incision sites with no erythema; the remainder of the examination is limited due to agitation.&nbsp; Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32062\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Alcohol withdrawal syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><p align=\"center\"><strong>Symptoms/signs</strong></p></td><td><p align=\"center\"><strong>Onset since last drink (hr)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mild withdrawal</strong></p></td><td><p>Anxiety, insomnia, tremors, diaphoresis, palpitations, gastrointestinal upset, intact orientation</p></td><td><p align=\"center\">6-24</p></td></tr><tr><td><p align=\"center\"><strong>Seizures</strong></p></td><td><p>Single or multiple generalized tonic-clonic</p></td><td><p align=\"center\">12-48</p></td></tr><tr><td><p align=\"center\"><strong>Alcoholic hallucinosis</strong></p></td><td><p>Visual, auditory, or tactile; intact orientation; stable vital signs</p></td><td><p align=\"center\">12-48</p></td></tr><tr><td><p align=\"center\"><strong>Delirium tremens</strong></p></td><td><p>Confusion, agitation, fever, tachycardia, hypertension, diaphoresis, hallucinations</p></td><td><p align=\"center\">48-96</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>delayed onset</strong> (&gt;48 hr following hospital admission) of severe <strong>delirium</strong>, <strong>elevated vital signs</strong> (eg, hyperthermia, hypertension, tachycardia), and <strong>diaphoresis</strong> in the setting of known polysubstance use is consistent with a diagnosis of <strong>delirium tremens</strong> (DT).&nbsp; DT is a <strong>late complication</strong> of <strong>alcohol withdrawal</strong> that may affect up to 5% of patients who experience an initial mild withdrawal syndrome.&nbsp; DT does not present before 48 hours after the last drink, and symptoms may take as long as 96 hours to be seen.&nbsp; After onset, symptoms may persist for up to 5 days and are associated with a mortality rate of up to 5%.</p><p>Treatment of DT is similar to that for milder forms of alcohol withdrawal:&nbsp; <strong>Benzodiazepines</strong> (eg, lorazepam, diazepam) are the pharmacologic treatment of choice.&nbsp; However, DT is the most severe form of alcohol withdrawal and usually requires management in an intensive care unit.</p><p><strong>(Choice A)</strong>&nbsp; Patients having an acute psychotic episode may experience bizarre delusions or hallucinations, but fever, tachycardia, hypertension, and diaphoresis suggest DT rather than a psychiatric disorder.</p><p><strong>(Choice C)</strong>&nbsp; Antidepressant discontinuation syndrome can occur when antidepressants are stopped abruptly or tapered too quickly.&nbsp; Symptoms are typically mild and include nausea, fatigue, headache, and dizziness.&nbsp; Agitation and diaphoresis are possible, but fever and abnormal vital signs would not be expected.</p><p><strong>(Choice D)</strong>&nbsp; Malignant hyperthermia is characterized by muscle rigidity, rhabdomyolysis, hyperthermia, and tachycardia immediately following the administration of a volatile inhaled anesthetic (eg, halothane, sevoflurane) in genetically susceptible individuals.</p><p><strong>(Choice E)</strong>&nbsp; Opioid withdrawal may present with agitation, diaphoresis, hypertension (usually mild), and tachycardia.&nbsp; However, gastrointestinal upset (eg, cramping, diarrhea), flu-like symptoms (eg, piloerection, rhinorrhea, myalgia), and yawning are also typically present.&nbsp; Delirium and fever would not be expected.</p><p><strong>(Choice F)</strong>&nbsp; Postoperative encephalopathy is most commonly associated with cardiac surgery and presents with delirium and/or seizures in the immediate postoperative period.&nbsp; The delayed onset of this patient&#39;s symptoms, her history of polysubstance use, and the presence of abnormal vital signs make DT more likely.</p><p><strong>Educational objective:</strong><br>Delirium tremens is a late manifestation of alcohol withdrawal characterized by delirium, hyperthermia, hypertension, and tachycardia 48-96 hours after the last drink.&nbsp; It requires aggressive management with benzodiazepines, usually in the intensive care unit.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 16983,
            "topic": "Alcohol withdrawal",
            "titleId": 16983,
            "title": "Alcohol withdrawal",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute psychotic episode",
                    "choiceNumber": 1,
                    "correctTaken": 226,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 2,
                    "correctTaken": 9881,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antidepressant discontinuation syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 1248,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant hyperthermia",
                    "choiceNumber": 4,
                    "correctTaken": 926,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opioid withdrawal",
                    "choiceNumber": 5,
                    "correctTaken": 1032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postoperative encephalopathy",
                    "choiceNumber": 6,
                    "correctTaken": 2978,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1021,1125,true,-1,1*160,186,true,-1,1*187,208,true,-1,1*347,385,true,-1,1*409,419,true,-1,1*478,492,true,-1,1*1868,1922,true,-1,1*2513,2816,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "592",
                    "mediaDataId": 0,
                    "title": "Alcohol use and its complications",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24399242",
                    "mediaDataId": 0,
                    "title": "Alcohol withdrawal deliriumdiagnosis, course and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24399242",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28188055",
                    "mediaDataId": 0,
                    "title": "The emergency medicine management of severe alcohol withdrawal.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28188055",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30564004",
                    "mediaDataId": 0,
                    "title": "Delirium tremens: assessment and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30564004",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 247,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16291,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1559,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 13785,
            "questionIndex": 15179,
            "questionText": "<p>An 8-year-old boy is brought to the office by his parents for behavioral concerns and poor school performance.&nbsp; They think that the patient is being &#x22;lazy and difficult&#x22; because he refuses to follow directions.&nbsp; Teachers note that he has a hard time focusing and is &#x22;constantly fidgeting&#x22; in his seat.&nbsp; The patient is in the third grade, but his math and reading skills are at a first-grade level.&nbsp; He has difficulty making friends and frequently gets into fights with his peers.&nbsp; The patient has no chronic medical conditions except for poor weight gain.&nbsp; Weight and height are at the 10th percentile; head circumference is &lt;3rd<font size=\"2\"><sup> </sup></font>percentile for his age.&nbsp; Physical examination reveals a cheerful patient with epicanthal folds and an upturned nose.&nbsp; The upper lip is thin, and the distance between the medial and lateral canthi of the eyes appears short.&nbsp; Cardiopulmonary and neurologic examinations are normal.&nbsp; Which of the following additional pieces of history would most likely account for this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31436\"><table class=\"table-default-style table-header-footer-style\" style=\"width:414px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Features of fetal alcohol syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Facial<br>dysmorphisms</strong></p></td><td><ul><li>Smooth philtrum</li><li>Thin vermillion border</li><li>Small palpebral fissures</li></ul></td></tr><tr><td><p align=\"center\"><strong>Growth</strong></p></td><td><ul><li>Height, weight &amp; head circumference &lt;10th percentile</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neurobehavioral</strong></p></td><td><ul><li>Developmental delay</li><li>Cognitive impairment</li><li>Behavioral issues (eg, ADHD, poor social skills)</li><li>Seizures</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ADHD</strong> = attention deficit hyperactivity disorder.</p></td></tr></tbody></table></div><p>This patient with behavioral concerns and learning difficulties also has poor growth, microcephaly, and facial dysmorphisms.&nbsp; These findings are concerning for <strong>fetal alcohol syndrome</strong> (FAS) due to in utero alcohol exposure; a thorough history of <strong>prenatal substance use</strong> should be obtained.</p><p>Alcohol is a teratogen that crosses the placenta to the fetus and can result in a range of neurobehavioral abnormalities, including reduced brain growth, particularly in the frontal lobe.&nbsp; FAS can manifest with symptoms of <strong>attention deficit hyperactivity disorder</strong> (ADHD), as seen in this patient with difficulty focusing and constant fidgeting.&nbsp; <strong>Cognitive impairment</strong> (eg, learning disabilities) and <strong>poor social skills</strong> are common due to deleterious effects on the prefrontal cortex.</p><p>In addition to neurobehavioral abnormalities, FAS is associated with <strong>growth restriction</strong> (height and weight typically &lt;10th percentile) and <a href=\"2224\">facial dysmorphisms</a>.&nbsp; A <strong>smooth philtrum</strong>, <strong>thin upper lip</strong>, and <strong>small palpebral fissures</strong> (distance between medial and lateral canthi) are characteristic of FAS, but other findings may include epicanthal folds and an upturned nose, as seen in this patient, as well as midface hypoplasia.</p><p><strong>(Choice A)</strong>&nbsp; Lead poisoning can present with cognitive impairment and behavioral issues but would not explain this patient&#39;s dysmorphic facial features.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"3438\">Fragile X syndrome</a> is the most common inherited cause of intellectual disability, and behavioral issues (eg, ADHD, autism) are commonly associated with it.&nbsp; However, stereotypical physical features include a long, narrow face and prominent ears, chin, and forehead.&nbsp; In addition, a relatively large head size, not microcephaly, would be expected.</p><p><strong>(Choice C)</strong>&nbsp; Late congenital syphilis due to infection acquired in utero can cause intellectual disability, but characteristic craniofacial findings include frontal bossing, <a href=\"42468\">saddle nose</a>, and <a href=\"22197\">Hutchinson teeth</a>, not a thin upper lip or short palpebral fissures.</p><p><strong>(Choice D)</strong>&nbsp; International travel during pregnancy may increase the risk for intrauterine exposure to Zika virus, which can cause microcephaly, growth restriction, and cognitive deficits.&nbsp; However, neurologic manifestations often develop in infancy and include hypertonia, hyperreflexia, and spasticity, findings not seen in this patient.&nbsp; In addition, a thin upper lip and short palpebral fissures are not associated with congenital Zika infection.</p><p><strong>Educational objective:</strong><br>Fetal alcohol syndrome should be considered in a patient with neurobehavioral issues (eg, cognitive impairment, attention deficit hyperactivity disorder, poor social skills), growth restriction, and facial dysmorphisms.&nbsp; Characteristic findings include a smooth philtrum, thin upper lip, and short palpebral fissures.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 12049,
            "topic": "Fetal alcohol syndrome",
            "titleId": 12049,
            "title": "Fetal alcohol syndrome",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Early childhood lead exposure",
                    "choiceNumber": 1,
                    "correctTaken": 144,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Family history of intellectual disability",
                    "choiceNumber": 2,
                    "correctTaken": 1764,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "In utero exposure to a sexually transmitted disease",
                    "choiceNumber": 3,
                    "correctTaken": 329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal international travel during pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 294,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prenatal substance use",
                    "choiceNumber": 5,
                    "correctTaken": 18208,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "156,208,true,-1,1*315,323,true,-1,1*288,314,true,-1,1*813,847,true,-1,1*1089,1142,true,-1,1*1471,1508,true,-1,1*1546,1564,true,-1,1*2436,2446,true,-1,1*2532,2672,true,-1,1*1755,1884,true,-1,1*2012,2076,true,-1,1*2088,2182,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27464676",
                    "mediaDataId": 0,
                    "title": "Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27464676",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28460370",
                    "mediaDataId": 0,
                    "title": "Comorbid mental disorders in fetal alcohol spectrum disorders: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28460370",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 20739,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 88,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1069,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 13714,
            "questionIndex": 15104,
            "questionText": "<p>A 46-year-old woman with alcohol use disorder comes to the office for follow-up.&nbsp; The patient has a prolonged history of heavy alcohol use and was hospitalized 6 months ago due to alcohol-induced pancreatitis.&nbsp; She stopped drinking after the hospitalization but restarted following a fight with her husband a month ago.&nbsp; Her daughters convinced her to stop again, and she has had no drinks for the past 2 weeks.&nbsp; The patient reports no anxiety or shakiness but has had occasional cravings and is afraid that she may relapse again.&nbsp; She has no other medical conditions, takes no medications, and does not use tobacco or illicit drugs.&nbsp; Vital signs are within normal limits, and physical examination shows no abnormalities.&nbsp; In addition to psychosocial interventions, which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40597\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Alcohol use disorder</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical features</strong></p></td><td><ul><li>Drinking in larger amounts, inability to cut down, cravings</li><li>Drinking in hazardous situations, failure to fulfill role obligations, continued drinking despite health/psychological/interpersonal problems</li><li>Evidence of tolerance &amp; withdrawal</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Psychosocial treatment</strong></p></td><td><ul><li>Motivational interviewing</li><li>Cognitive-behavioral therapy</li><li>Residential treatment/rehabilitation</li><li>Mutual help groups (eg, Alcoholics Anonymous)</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Pharmacotherapy</strong></p></td><td><ul><li>Naltrexone</li><li>Acamprosate (preferred in patients with liver disease or opioid use)</li><li>Disulfiram is second-line therapy in highly motivated patients</li></ul></td></tr></tbody></table></div><p>Patients with moderate to severe <strong>alcohol use disorder</strong> (AUD) should be offered pharmacotherapy in addition to psychosocial interventions.&nbsp; Medications that target the reinforcing effects of alcohol by modulating opioid and glutamate function have been shown to decrease cravings, reduce alcohol consumption, and help maintain abstinence.</p><ul><li><p><strong>Acamprosate</strong>, a <strong>glutamate modulator</strong> at metabotropic glutamate receptor 5, is a first-line treatment that would help reduce this patient&#39;s risk of relapse.&nbsp; It is excreted mostly unchanged by the kidneys, and can be used safely in patients with liver disease, but requires dosage adjustment in patients with renal failure.</p></li><li><p><strong>Naltrexone</strong>, a <strong>mu-opioid receptor antagonist</strong>, is another first-line option for AUD.&nbsp; However, it has been associated with hepatotoxicity and is contraindicated in patients with liver disease and those taking prescribed opioid medication.</p></li></ul><p><strong>(Choice B)</strong>&nbsp; Benzodiazepines (eg, chlordiazepoxide) are indicated for the treatment of moderate to severe alcohol withdrawal.&nbsp; They do not treat AUD and have a high risk of abuse.&nbsp; This patient has been abstinent for 2 weeks and shows no signs of withdrawal.</p><p><strong>(Choice C)</strong>&nbsp; Disulfiram, an aldehyde dehydrogenase inhibitor, is an aversive agent that causes an unpleasant physiologic reaction (eg, tachycardia, flushed skin, headache, nausea, vomiting) when alcohol is consumed.&nbsp; Candidates for disulfiram must be highly motivated or supervised because they may skip a dose to avoid the averse reaction when alcohol is desired.&nbsp; It is considered a second-line agent for use when naltrexone and acamprosate are either ineffective or contraindicated.</p><p><strong>(Choice D)</strong>&nbsp; Fomepizole is an alcohol dehydrogenase inhibitor used as an antidote to treat methanol or ethylene glycol poisoning.</p><p><strong>(Choice E)</strong>&nbsp; Naloxone is a short-acting opioid antagonist used to treat acute opioid intoxication.</p><p><strong>Educational objective:</strong><br>A combination of psychosocial interventions and pharmacotherapy is indicated for patients with moderate to severe alcohol use disorder.&nbsp; Acamprosate and naltrexone are first-line medication options.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24408,
            "topic": "Alcohol use disorder",
            "titleId": 24408,
            "title": "Alcohol use disorder",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acamprosate",
                    "choiceNumber": 1,
                    "correctTaken": 10211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chlordiazepoxide",
                    "choiceNumber": 2,
                    "correctTaken": 882,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disulfiram",
                    "choiceNumber": 3,
                    "correctTaken": 6709,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fomepizole",
                    "choiceNumber": 4,
                    "correctTaken": 1101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Naloxone",
                    "choiceNumber": 5,
                    "correctTaken": 2253,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1996,2265,true,-1,1*1428,1522,true,-1,1*1222,1284,true,-1,1*1170,1220,true,-1,1*2356,2394,true,-1,1*1792,1840,true,-1,1*2277,2326,true,-1,1*483,625,true,-1,1*886,962,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "592",
                    "mediaDataId": 0,
                    "title": "Alcohol use and its complications",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24825644",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24825644",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26084940",
                    "mediaDataId": 0,
                    "title": "Acamprosate: a review of its use in alcohol dependence.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26084940",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29445407",
                    "mediaDataId": 0,
                    "title": "Practical outpatient pharmacotherapy for alcohol use disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29445407",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 21156,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 930,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 20135,
            "questionIndex": 21629,
            "questionText": "<p>A 6-year-old boy is brought to the office by his mother due to learning difficulties at school.&nbsp; The patient was adopted from an overseas orphanage at age 5 and stayed home until beginning kindergarten 6 months ago.&nbsp; His birth and developmental history are unknown.&nbsp; Since beginning school, he has struggled to keep up with reading and writing.&nbsp; Educational testing was completed and showed an intelligence quotient (IQ) of 68.&nbsp; Audiology revealed a mild conductive hearing loss in his right ear.&nbsp; The patient&#39;s mother says, &#x22;He is a really happy kid and enjoys playing with his older siblings.&nbsp; I know he doesn&#39;t talk as much as other kids his age, but I thought that would improve with time.&#x22;&nbsp; Vital signs are within normal limits; weight and height curves are at the 70th and 10th percentiles, respectively.&nbsp; The patient is sitting on the floor playing with a range of toys.&nbsp; Physical examination is significant for a flat nasal bridge and a grade 3 holosystolic murmur at the lower left sternal border.&nbsp; He makes eye contact, has a friendly demeanor, and responds to questions with 3- to 4-word phrases.&nbsp; Which of the following tests is most likely to reveal the diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T73974\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Common causes of intellectual disability</strong></p></td></tr><tr><td><p align=\"center\"><strong>Syndrome</strong></p></td><td><p align=\"center\"><strong>Dysmorphic features</strong></p></td><td><p align=\"center\"><strong>Comorbid conditions</strong></p></td></tr><tr><td><p align=\"center\"><strong>Down syndrome</strong></p></td><td><ul><li>Upslanting palpebral fissures</li><li>Flat nasal bridge</li><li>Epicanthal folds</li><li>Single palmar crease</li></ul></td><td><ul><li>Heart disease (eg, AV canal defect)</li><li>Short stature, obesity</li><li>Hearing loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fragile X syndrome</strong></p></td><td><ul><li>Long face with prominent chin &amp; forehead</li><li>Large, protruding ears</li><li>Macroorchidism</li><li>Macrocephaly</li></ul></td><td><ul><li>Self-injurious behavior (eg, hand biting)</li><li>Anxiety, autistic behaviors</li><li>Tall stature</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fetal alcohol syndrome</strong></p></td><td><ul><li>Smooth philtrum</li><li>Thin vermillion border</li><li>Small palpebral fissures</li></ul></td><td><ul><li>Seizures</li><li>Growth restriction</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>AV</strong> = atrioventricular.</p></td></tr></tbody></table></div><p>This patient with learning difficulties and a low intelligence quotient (IQ) has <strong>intellectual disability</strong>.&nbsp; In the setting of dysmorphic features or a family history of intellectual disability, a <strong>genetic cause</strong> should be suspected.</p><p>In this case, the most likely cause is <strong>Down syndrome</strong>, the most common chromosomal abnormality associated with intellectual disability.&nbsp; <strong>Congenital heart defects</strong> (eg, atrioventricular defect, ventricular septal defect [VSD]) occur in 50% of patients; the holosystolic murmur in this case is consistent with a VSD.&nbsp; <strong>Hearing impairment</strong> due to congenital hearing loss or frequent otitis media is also common.&nbsp; Patients often have a friendly demeanor and poor vertical growth, as seen here.</p><p>The diagnosis is frequently established based on prenatal testing or characteristic <a href=\"2641\">dysmorphic features at birth</a> (eg, flat nasal bridge).&nbsp; However, in a patient with mosaicism (extra copy of chromosome 21 in some cells), such dysmorphic features may be <strong>less prominent</strong> and diagnosis may be delayed.&nbsp; A <strong>karyotype</strong> should be performed; identification of trisomy 21 is diagnostic.</p><p><strong>(Choice A)</strong>&nbsp; <em>FMR1</em> DNA analysis detects the gene mutation responsible for Fragile X syndrome (FXS).&nbsp; Boys with <a href=\"3438\">FXS</a> typically have tall stature and a long, narrow face, not a flat nasal bridge.&nbsp; FXS also would not explain this patient&#39;s hearing loss or murmur.</p><p><strong>(Choice C)</strong>&nbsp; Rett syndrome, typically due to <em>MECP2</em> mutations, is a neurodevelopmental disorder characterized by loss of speech after a period of normal development, as well as stereotypical hand movements and gait abnormalities.&nbsp; It occurs almost exclusively in girls.</p><p><strong>(Choice D)</strong>&nbsp; MRI of the head is indicated for focal neurologic deficits, seizures, or progressive degenerative neurologic symptoms.&nbsp; MRI findings in patients with mild intellectual disability are often normal or nonspecific and would not diagnose DS.</p><p><strong>(Choice E)</strong>&nbsp; Serum hexosaminidase A levels should be measured for suspected Tay-Sachs disease, a lysosomal storage disease that usually presents in infancy with severe neurodegeneration (eg, progressive weakness, loss of motor skills) and death by age 2-5.</p><p><strong>(Choice F)</strong>&nbsp; Phenylketonuria, an autosomal recessive disorder caused by phenylalanine hydroxylase deficiency, causes intellectual disability; however, other characteristic features (eg, musty odor, seizure, hypopigmented skin) also would be expected.&nbsp; In addition, it is not associated with heart disease or hearing loss.</p><p><strong>Educational objective:</strong><br>Down syndrome should be suspected in a child with intellectual disability and characteristic dysmorphic features, cardiac defects, and hearing loss.&nbsp; Trisomy 21 on karyotype is diagnostic.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 12637,
            "topic": "Down syndrome",
            "titleId": 12637,
            "title": "Down syndrome",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>FMR1</em> DNA analysis",
                    "choiceNumber": 1,
                    "correctTaken": 613,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Karyotype analysis",
                    "choiceNumber": 2,
                    "correctTaken": 3621,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>MECP2</em> gene analysis",
                    "choiceNumber": 3,
                    "correctTaken": 324,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the head",
                    "choiceNumber": 4,
                    "correctTaken": 208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum hexosaminidase A level",
                    "choiceNumber": 5,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum phenylalanine level",
                    "choiceNumber": 6,
                    "correctTaken": 109,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2504,2747,true,-1,1*279,291,true,-1,1*220,255,true,-1,1*573,581,true,-1,1*390,402,true,-1,1*403,444,true,-1,1*454,472,true,-1,1*1019,1076,true,-1,1*1107,1165,true,-1,1*1478,1715,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29218069",
                    "mediaDataId": 0,
                    "title": "Down syndromegenetics and cardiogenetics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29218069",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24127006",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of Down syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24127006",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 119,
            "othersAvgTimeSpent": 93,
            "notes": null,
            "peopleTaken": 5062,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1247,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 4893,
            "questionIndex": 4893,
            "questionText": "<p>A 2-day-old term neonate is evaluated for difficulty feeding in the newborn nursery.&nbsp; The patient is irritable, is not sleeping well, and has had several episodes of vomiting and loose stools for the past day.&nbsp; Review of maternal history shows that the mother had poor prenatal care and the pregnancy was complicated by fetal growth restriction.&nbsp; On examination, the patient is diaphoretic with a high-pitched cry and a mild tremor.&nbsp; The newborn is noted to have occasional sneezing and is mildly tachypneic.&nbsp; No dysmorphic features are noted, and the remainder of the examination is unremarkable.&nbsp; Complete blood count, thyroid screening, serum glucose, and calcium levels are within normal limits.&nbsp; Which of the following is the most appropriate treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t57289\"><table class=\"table-default-style\" style=\"width:576px\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%;\"><p align=\"center\" style=\"margin-left:.3in;\"><strong>Neonatal abstinence syndrome</strong></p></td></tr><tr><td style=\"width:23.96%;\"><p align=\"center\"><strong>Pathophysiology</strong></p></td><td style=\"width:76.04%;\"><ul><li>In utero exposure to maternal substances (primarily opioids)</li></ul></td></tr><tr><td style=\"width:23.96%;\"><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td style=\"width:76.04%;\"><ul><li>CNS: irritability, hypertonia, tremor, shortened sleep-wake cycles, uncoordinated swallowing</li><li>Autonomic nervous system: diaphoresis, sneezing, yawning</li><li>Gastrointestinal: feeding difficulty, vomiting, diarrhea</li></ul></td></tr><tr><td style=\"width:23.96%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:76.04%;\"><ul><li>Primarily clinical</li><li>Confirm: umbilical cord blood, urine, or meconium drug testing</li></ul></td></tr><tr><td style=\"width:23.96%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:76.04%;\"><ul><li>Mild withdrawal: nonpharmacologic<ul style=\"list-style-type:circle;\"><li>Minimize environmental stimuli, swaddling, frequent small feeds</li></ul></li><li>Moderate to severe withdrawal: pharmacologic<ul style=\"list-style-type:circle;\"><li>Morphine, methadone</li></ul></li></ul></td></tr></tbody></table></div><p>This 2-day-old patient with irritability, diaphoresis, and poor feeding most likely has <strong>neonatal abstinence syndrome (NAS)</strong>, also known as neonatal opioid withdrawal syndrome.</p><p>During pregnancy, maternal opioids (eg, methadone, buprenorphine, heroin) cross the placenta and act on the fetus; chronic intrauterine exposure can cause <strong>fetal growth restriction</strong>, although other factors (eg, polysubstance use, nutrition) may play a role.&nbsp; After delivery, the abrupt cessation of chronic opioid exposure causes withdrawal.&nbsp; NAS typically presents within 48 hours of birth for patients exposed to short-acting opioids (eg, heroin) and within 48-72 hours for those exposed to long-acting opioids (eg, methadone).&nbsp; Clinical manifestations of withdrawal include the following:</p><ul><li>CNS:&nbsp; Short sleep-wake cycles, <strong>irritability</strong>, hypertonicity, <strong>tremors</strong>, jitteriness</li><li>Autonomic nervous system (ANS):&nbsp; Sweating, <strong>sneezing</strong>, nasal stuffiness, yawning</li><li>Gastrointestinal (GI) system:&nbsp; Poor feeding, vomiting, <strong>loose stools</strong></li></ul><p>Neonates with mild symptoms require only supportive care (swaddling; small, frequent feeds; low-stimulation environment) while their symptoms self-resolve.&nbsp; Patients with moderate to severe symptoms, such as this newborn, require <strong>opioid replacement</strong> (eg, methadone, <strong>morphine</strong>) to manage their symptoms and allow them to feed and gain weight.</p><p><strong>(Choice A)</strong>&nbsp; Patients with apnea of prematurity are treated with caffeine.&nbsp; Although this condition may cause tachypnea and subsequent difficulty feeding, it is unlikely the diagnosis because of this patient&#39;s GI and ANS symptoms.</p><p><strong>(Choice B)</strong>&nbsp; In infants, famotidine is used to treat gastroesophageal reflux disease (GERD), which can present with feeding difficulties and vomiting.&nbsp; GERD would not cause this patient&#39;s CNS and ANS symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Congenital syphilis can cause fetal growth restriction and nasal discharge; however, patients are asymptomatic at birth and develop symptoms at age 1-2 weeks.&nbsp; Congenital syphilis is treated with penicillin, but this patient&#39;s symptom timeline makes this diagnosis less likely.</p><p><strong>(Choice E)</strong>&nbsp; Propranolol is used in the treatment of neonatal Graves disease, which results from the placental transfer of maternal thyroid-stimulating antibodies.&nbsp; Neonatal Graves disease has a similar presentation to that of NAS (eg, fetal growth restriction, irritability, increased bowel movements); however, this patient&#39;s normal thyroid function tests make this diagnosis less likely.</p><p><strong>Educational objective:</strong><br>Neonatal abstinence syndrome is caused by neonatal withdrawal from maternal opioids in the first few days of life.&nbsp; It is characterized by irritability, a high-pitched cry, poor sleep, tremors, sneezing, tachypnea, poor feeding, vomiting, and diarrhea.&nbsp; Newborns with moderate to severe symptoms are treated with methadone or morphine.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14961,
            "topic": "Opioids",
            "titleId": 14961,
            "title": "Opioids",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Caffeine",
                    "choiceNumber": 1,
                    "correctTaken": 1436,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Famotidine",
                    "choiceNumber": 2,
                    "correctTaken": 1015,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Morphine",
                    "choiceNumber": 3,
                    "correctTaken": 10679,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penicillin",
                    "choiceNumber": 4,
                    "correctTaken": 1405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 5,
                    "correctTaken": 1556,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "165,252,true,-1,1*404,457,true,-1,1*612,631,true,-1,1*770,806,true,-1,1*847,900,true,-1,1*1147,1335,true,-1,1*2416,2693,true,-1,1*1976,2037,true,-1,1*2706,3083,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28406856",
                    "mediaDataId": 0,
                    "title": "Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28406856",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26232620",
                    "mediaDataId": 0,
                    "title": "Neonatal abstinence syndrome: historical perspective, current focus, future directions",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26232620",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 46,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16091,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1145,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 22170,
            "questionIndex": 106025,
            "questionText": "<p>A 45-year-old woman is called to the office for a random pill count and urine drug screen as a part of chronic pain management with hydrocodone/acetaminophen.&nbsp; The patient has chronic back pain due to a ski accident 5 months ago.&nbsp; She is prescribed 1 tablet of hydrocodone/acetaminophen in the morning and 1 tablet in the evening and reported adequate control of her pain at her last follow-up 3 weeks ago.&nbsp; A query of the prescription drug monitoring database shows she consistently filled 60 tablets of hydrocodone/acetaminophen every 30 days; the prescription was last filled 15 days ago.&nbsp; Today, a pill count reveals the patient has 10 tablets of hydrocodone/acetaminophen remaining.&nbsp; Urine drug test confirms the absence of opioids and other tested drugs.&nbsp; Which of the following is the most appropriate next step in the management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Random <strong>pill counts</strong> and <strong>urine drug screenings</strong> are commonly used in chronic opioid therapy to identify <strong>opioid misuse</strong>.&nbsp; This patient&#39;s urine drug test is negative for opioids despite reported adherence and on-time refills.&nbsp; Furthermore, her opioid consumption occurred at a higher rate than expected, as evidenced by the fewer-than-expected pill count (would expect 30 tablets to be remaining at 15 days based on her prescription).</p><p>These findings raise suspicion for opioid misuse, including opioid <strong>diversion</strong> (eg, sharing or selling a medication).&nbsp; Opioid diversion contributes to the public health threat of the opioid epidemic:&nbsp;opioid overdose frequently occurs in individuals who are not prescribed the medication but obtained it from others.&nbsp; In this patient with a remote injury,&nbsp;well controlled pain despite no opioid use (ie, negative urine drug test result), and a high suspicion for opioid diversion, future <strong>prescriptions should be suspended</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Frequent follow-up visits are recommended during opioid dose titrations to monitor response and adverse effects.&nbsp; Patients with a history of substance use disorder who are on chronic opioid therapy also should be seen more frequently.&nbsp; This patient is not taking her prescribed opioids, other controlled substances, or recreational&nbsp;drugs.</p><p><strong>(Choice B)</strong>&nbsp; Naloxone should be offered to any patient on chronic opioid therapy to prevent fatal overdose.&nbsp; This patient is prescribed opioids but not taking them (given the negative urine drug screen result).</p><p><strong>(Choice C)</strong>&nbsp; A medication-assisted treatment program (eg, buprenorphine, methadone) is recommended for those with opioid use disorder but is not helpful for diversion.</p><p><strong>(Choice E)</strong>&nbsp; Fentanyl transdermal patch is preferred over oral opioids when oral intake is difficult (eg, dysphagia), gastrointestinal absorption is compromised, opioid-related constipation is problematic, or renal function is impaired; these indications are not present in this patient.</p><p><strong>Educational objective:</strong><br>Opioid diversion (ie, sharing or selling of medication) should be suspected when a urine drug test confirms absence of opioids despite reported adherence to therapy.&nbsp; Opioid overdose frequently occurs in individuals who are not prescribed the medication but obtained it from others; when diversion is suspected, future prescriptions should be suspended.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14961,
            "topic": "Opioids",
            "titleId": 14961,
            "title": "Opioids",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Increase frequency of follow-up visits",
                    "choiceNumber": 1,
                    "correctTaken": 882,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe naloxone for home use and traveling",
                    "choiceNumber": 2,
                    "correctTaken": 389,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer to medication-assisted treatment program",
                    "choiceNumber": 3,
                    "correctTaken": 541,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suspend future opioid prescriptions",
                    "choiceNumber": 4,
                    "correctTaken": 2975,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch to long-acting fentanyl patch",
                    "choiceNumber": 5,
                    "correctTaken": 380,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1719,1942,true,-1,1*1340,1437,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25587948",
                    "mediaDataId": 0,
                    "title": "Trends in opioid analgesic abuse and mortality in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25587948",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 5167,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 765,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 19932,
            "questionIndex": 21421,
            "questionText": "<p>A 37-year-old man comes to the emergency department for evaluation of back pain.&nbsp; The patient was seen 2 days ago in the emergency department for similar pain symptoms and was discharged on naproxen.&nbsp; Medical history is significant for asthma, hepatitis C, and opioid use disorder.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 138/92 mm Hg, and pulse is 104/min.&nbsp; The patient is irritable while his vital signs are being taken and angrily says to the nurse, &#x22;That medication I got was useless.&nbsp; My pain is now 10 times worse.&#x22;&nbsp; His speech is very loud, filled with expletives, and disruptive to patients in adjacent rooms.&nbsp; His fists are clenched.&nbsp; Which of the following is the most appropriate next step in management of the patient interview?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t70795\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Aggressive patient in the emergency department</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>History of violent behavior/antisocial personality disorder&nbsp;</li><li>Psychiatric illness (eg, psychosis, delirium, suicidal/homicidal ideation)</li><li>Substance use; acute intoxication, withdrawal</li><li>Prolonged wait times</li></ul></td></tr><tr><td><p align=\"center\"><strong>Warning signs</strong></p></td><td><ul><li>Angry, irritable demeanor</li><li>Loud, aggressive speech, cursing, verbal threats</li><li>Tense posture, clenched fists, pacing</li><li>Desk or wall pounding, throwing objects</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Maintain a distance of 2 arm lengths; avoid direct eye contact</li><li>Interview with door open, clinician closer to the exit</li><li>Verbal deescalation<ul style=\"list-style-type:circle;\"><li>Use calm voice, nonconfrontational approach</li><li>Provide for basic needs (eg, offer food, drink, blanket)</li><li>Listen attentively to clarify patient&#39;s wants/needs</li><li>Set clear expectations that violence is unacceptable; reinforce that patient will not be harmed</li><li>Offer choices if appropriate (eg, oral vs intramuscular medications)</li></ul></li><li>Chemical &amp; physical restraint when verbal deescalation fails &amp; violence is imminent</li></ul></td></tr></tbody></table></div><p>This patient is showing multiple signs of <strong>increasing agitation</strong> (eg, irritable demeanor, loud speech, cursing, clenched fists), which could escalate to violent behavior.&nbsp; He is angry about his recent treatment in the emergency department and could pose a threat to staff if he feels his current needs are not being met.&nbsp; Emergency department staff must be alert to <strong>verbal and nonverbal signs</strong> of escalating agitation and take steps to minimize safety risks to other patients and staff.</p><p>The most appropriate approach is to listen attentively to the patient&#39;s needs during the interview after arranging for <strong>security personnel</strong> to be standing <strong>nearby</strong> should the patient become violent.&nbsp; In addition, the <strong>door should remain open</strong> so staff is not trapped behind a barrier with the patient.&nbsp; Seating should be arranged so that the physician (not the patient) is seated closest to the exit to facilitate escape.&nbsp; Objects that can be used as weapons should be removed from the room.&nbsp; A panic button or agreed-upon code word can be used to alert security.</p><p><strong>(Choice A)</strong>&nbsp; Closing the door and asking the patient to calm down places the physician at increased risk.&nbsp; Asking a patient to calm down can be perceived as condescending and have the unintended effect of making the patient angrier.&nbsp; A closed door makes escape more difficult.</p><p><strong>(Choice B)</strong>&nbsp; Although it is appropriate to set limits that verbal abuse and violent behavior are unacceptable, threatening to withhold treatment is likely to be experienced as confrontational and may further escalate the situation.</p><p><strong>(Choices C and D)</strong>&nbsp; Informing the patient that he will be restrained or that security personnel will be called will likely make the patient feel that his needs are being ignored, leading to further agitation.&nbsp; These statements may be perceived as confrontational and threatening and provoke the patient to act out violently so as to exert some control and prove himself.&nbsp; It is safer to first try to engage the patient with a nonconfrontational approach and have the restraint team or security personnel nearby in case further intervention becomes necessary.</p><p><strong>Educational objective:</strong><br>Emergency department staff should be alert to verbal and nonverbal signs of escalating agitation and impending violence (eg, irritable demeanor, loud speech, cursing, tense posture, pacing, clenched fists).&nbsp; Management techniques include interviewing the patient with the door open to facilitate escape by the clinician and a system for alerting security personnel standing nearby.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 30867,
            "topic": "Aggression",
            "titleId": 30867,
            "title": "Aggression",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Close the patient&#39;s room door and ask him to calm down and lower his voice",
                    "choiceNumber": 1,
                    "correctTaken": 1093,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inform the patient that he will not be treated if he continues to be verbally abusive",
                    "choiceNumber": 2,
                    "correctTaken": 979,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inform the patient that restraints will be applied if he loses control",
                    "choiceNumber": 3,
                    "correctTaken": 149,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inform the patient that security personnel will be called if he continues to be aggressive",
                    "choiceNumber": 4,
                    "correctTaken": 2049,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interview the patient with the door open and have security personnel nearby",
                    "choiceNumber": 5,
                    "correctTaken": 13791,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "118,150,true,-1,1*174,224,true,-1,1*927,1010,true,-1,1*471,533,true,-1,1*653,709,true,-1,1*858,925,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27836151",
                    "mediaDataId": 0,
                    "title": "Violence in the emergency department.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27836151",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 171,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 18062,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 633,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 14382,
            "questionIndex": 15791,
            "questionText": "<p>A 19-year-old woman is brought to the emergency department by her father due to bizarre behavior.&nbsp; When the patient did not come down for breakfast this morning, her father went to her room and found her sitting up in bed, staring at the wall.&nbsp; The patient did not respond to questions and was very stiff when her father tried to help her stand.&nbsp; The patient was diagnosed with bipolar disorder last year.&nbsp; She takes lithium, risperidone, and fluoxetine.&nbsp; Her dosages of risperidone and fluoxetine were both increased recently to target residual depressive symptoms.&nbsp; Temperature is 36.6 C (97.9 F), blood pressure is 121/78 mm Hg, pulse is 68/min, and respirations are 14/min.&nbsp; When asked what today&#39;s date is, the patient repeats, &#x22;Date, date, date,&#x22; repeatedly.&nbsp; She resists the examiner&#39;s movement of her arms, increasing her resistance in proportion to the applied force.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39673\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Catatonia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Immobility or excessive purposeless activity&nbsp;</li><li>Mutism, stupor (decreased alertness &amp; response to stimuli)</li><li>Negativism (resistance to instructions &amp; movement)</li><li>Posturing (assuming positions against gravity)</li><li>Waxy flexibility (initial resistance, then maintenance of new posture)</li><li>Echolalia, echopraxia (mimicking speech &amp; movements)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Benzodiazepines (lorazepam)</li><li>Electroconvulsive therapy</li></ul></td></tr></tbody></table></div><p>This patient&#39;s acute onset of <strong>immobility</strong>, <strong>mutism</strong>, <strong>negativism</strong> (ie, proportional resistance to passive movement), and <strong>echolalia</strong> (ie, repeating another&#39;s words) are consistent with <strong>catatonia</strong>.&nbsp; Catatonia is a syndrome characterized by psychomotor signs/symptoms that occur in the context of psychiatric or medical illness.&nbsp; Catatonia most often develops in the context of a mood disorder (eg, bipolar disorder, major depressive disorder); however, it may also occur in psychotic disorders (eg, schizophrenia), autism spectrum disorder, and general medical illness.</p><p>Catatonia is most often treated with <strong>benzodiazepines</strong> (eg, lorazepam), but severe or intractable cases can be successfully treated with electroconvulsive therapy.&nbsp; Relief of symptoms in response to a lorazepam challenge test (usually intravenous lorazepam) supports the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Akinetic mutism is caused by lesions in the frontal cortex.&nbsp; It may present similarly to catatonia but is not accompanied by echophenomena (eg, echolalia, echopraxia).</p><p><strong>(Choice C)</strong>&nbsp; Delirium is a disorder of acute onset altered attention and arousal that fluctuates in severity across time.&nbsp; It would not explain this patient&#39;s motor symptoms or echophenomena.</p><p><strong>(Choice D)</strong>&nbsp; Drug-induced parkinsonism presents with resting tremor, bradykinesia, and rigidity; it is most often caused by dopamine-blocking agents (eg, antipsychotics).&nbsp; This patient&#39;s presentation, which includes mutism and echolalia, is better explained by catatonia.</p><p><strong>(Choice E)</strong>&nbsp; Locked-in syndrome is usually caused by a pontine stroke and presents with paralysis, mutism, and a preservation of cognitive abilities.</p><p><strong>(Choice F)</strong>&nbsp; Neuroleptic malignant syndrome presents with autonomic instability (eg, hyperthermia, tachycardia, hypertension), rigidity, and altered mental status in the setting of antipsychotic medication use.&nbsp; This patient is afebrile with normal vital signs.</p><p><strong>(Choice G)</strong>&nbsp; Serotonin syndrome is characterized by autonomic instability (eg, hyperthermia, tachycardia, hypertension), hyperreflexia, and altered mental status in the context of serotonergic medication use.&nbsp; It would not explain this patient&#39;s immobility, negativism, and normal vital signs.</p><p><strong>Educational objective:</strong><br>Catatonia is characterized by immobility, mutism, negativism, and echophenomena.&nbsp; It most often presents in the context of bipolar disorder or major depressive disorder.&nbsp; Catatonia is treated with benzodiazepines (eg, lorazepam).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 5953,
            "topic": "Catatonia",
            "titleId": 5953,
            "title": "Catatonia",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Akinetic mutism",
                    "choiceNumber": 1,
                    "correctTaken": 1377,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Catatonia",
                    "choiceNumber": 2,
                    "correctTaken": 13255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delirium",
                    "choiceNumber": 3,
                    "correctTaken": 269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug-induced parkinsonism",
                    "choiceNumber": 4,
                    "correctTaken": 1766,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Locked-in syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroleptic malignant syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 1198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin syndrome",
                    "choiceNumber": 7,
                    "correctTaken": 424,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "769,1010,true,-1,1*450,638,true,-1,1*1209,1266,true,-1,1*332,384,true,-1,1*1302,1363,true,-1,1*2019,2081,true,-1,1*2207,2217,true,-1,1*2462,2478,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29398916",
                    "mediaDataId": 0,
                    "title": "Systematic review of catatonia treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29398916",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28640169",
                    "mediaDataId": 0,
                    "title": "The use of lorazepam and electroconvulsive therapy in the treatment of catatonia: treatment characteristics and outcomes in 60 patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28640169",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25538636",
                    "mediaDataId": 0,
                    "title": "A clinical review of the treatment of catatonia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25538636",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 82,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 18586,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 765,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 14634,
            "questionIndex": 16048,
            "questionText": "<p>A 51-year-old man is evaluated for agitation and oppositional behavior.&nbsp; The patient has a long history of schizophrenia.&nbsp; He was admitted to a group home yesterday after his mother, with whom he previously lived, moved to an assisted care facility.&nbsp; A staff member from the group home reports the patient was cooperative and calm when he arrived and did not talk much, which seems to be his baseline.&nbsp; He did not sleep well last night, and today he has been pacing and yelling at other residents and staff.&nbsp; The patient has no other medical conditions.&nbsp; Medications include clozapine.&nbsp; He does not use tobacco or recreational drugs but does use alcohol.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 152/94 mm Hg, and pulse is 114/min.&nbsp; On physical examination, the patient appears anxious and diaphoretic and is fidgeting in his seat.&nbsp; Marked hand tremors are present.&nbsp; He is alert and oriented to person, place, and time.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Although it can go unrecognized, substance use disorder often occurs in patients with schizophrenia; up to 50% of patients with newly diagnosed schizophrenia already have a diagnosis of alcohol or drug use disorder.&nbsp; This patient with a history of schizophrenia and alcohol use has developed signs of <strong>alcohol withdrawal</strong>, likely precipitated by suddenly losing access to alcohol when he moved to a group home.&nbsp; Clues to the diagnosis include the time course of symptoms (eg, calm and cooperative the first day, <strong>restless</strong> and <strong>agitated</strong> the second day) and manifestations of sympathetic hyperactivity (eg, <strong>elevated blood pressure, tachycardia, diaphoresis</strong>, and <strong>tremor</strong>).</p><p><a href=\"2109\">Withdrawal symptoms</a> typically start within 6-24 hours after the last drink.&nbsp; Alcohol withdrawal seizures can occur within 12-48 hours, and delirium tremens (ie, disorientation, severe agitation, fever) typically begins within 48-96 hours.&nbsp; <strong>Benzodiazepines</strong> are the <strong>treatment of choice</strong> for psychomotor agitation associated with alcohol withdrawal and to prevent progression to seizures and delirium.&nbsp; Supportive psychological therapies may help with anxiety, but they do not slow the progression of alcohol withdrawal <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Benztropine is an anticholinergic medication sometimes used to treat antipsychotic-induced extrapyramidal symptoms (EPSs) such as akathisia (eg, restlessness) or parkinsonism (eg, tremor).&nbsp; However, EPSs are most commonly associated with high-potency, first-generation antipsychotics (eg, haloperidol) rather than second-generation antipsychotics (eg, clozapine).&nbsp; In addition, the hypertension, tachycardia, and diaphoresis exhibited by this patient are more consistent with alcohol withdrawal.</p><p><strong>(Choice C)</strong>&nbsp; Selective serotonin reuptake inhibitors are indicated for major depression or anxiety disorders and take up to 2 weeks to take effect.&nbsp; They would not be effective in managing acute anxiety or any adjustment symptoms resulting from the patient&#39;s move to the group home.&nbsp; In addition, the diaphoresis and tremor suggest alcohol withdrawal rather than anxiety or adjustment symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Discontinuing clozapine would be necessary if this patient had neuroleptic malignant syndrome (NMS), a life-threatening condition associated with the use of antipsychotic agents.&nbsp; NMS can present with agitation and autonomic instability (eg, tachycardia); however, hyperthermia and muscle rigidity are also typically present.&nbsp; Clozapine is generally used in conditions refractory to other antipsychotic medications; its discontinuation in this patient would likely result in significant worsening of his psychiatric condition.</p><p><strong>Educational objective:</strong><br>Alcohol use disorder often goes unrecognized in patients with schizophrenia and should be considered in patients&nbsp; who develop acute agitation, diaphoresis, tremor, elevated blood pressure, and tachycardia following admission to a supervised setting.&nbsp; Benzodiazepines are the treatment of choice.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 16983,
            "topic": "Alcohol withdrawal",
            "titleId": 16983,
            "title": "Alcohol withdrawal",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add benztropine",
                    "choiceNumber": 1,
                    "correctTaken": 3606,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administer benzodiazepine",
                    "choiceNumber": 2,
                    "correctTaken": 7953,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin selective serotonin reuptake inhibitor",
                    "choiceNumber": 3,
                    "correctTaken": 1934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue clozapine",
                    "choiceNumber": 4,
                    "correctTaken": 405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend brief psychotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 531,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29912213",
                    "mediaDataId": 0,
                    "title": "Alcohol withdrawal syndrome: diagnostic and therapeutic methods.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29912213",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 121,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 14429,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 543,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 19193,
            "questionIndex": 20677,
            "questionText": "<p>A 16-year-old boy is brought to the office by his mother due to behavioral concerns.&nbsp; The patient has been coming home after curfew most nights and arguing with his parents more than usual.&nbsp; The mother notes that he has been spending most of his time at home alone in his room with the door closed and seems less interested in attending family get-togethers.&nbsp; The mother also shares that she found a marijuana joint under the patient&#39;s bed last week; when asked about the joint, he stated it belongs to a friend and he does not use drugs.&nbsp; The patient maintains a B average in school and plays in the high school band.&nbsp; When interviewed alone, the patient states he has tried marijuana a few times and lied to his mother because he was afraid that she would tell his father.&nbsp; The patient says he would rather avoid talking to his father for as long as possible and shares that his father refers to him as a disappointment.&nbsp; He has no chronic medical conditions and takes no medications.&nbsp; Vital signs are normal; growth curves are tracking consistently.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This adolescent&#39;s behavioral concerns appear to center around his relationship with his parents (ie, lying to his mother, breaking curfew rules, increased arguing, avoiding conversations with his father).&nbsp; When seen individually, he expresses fear about his father&#39;s judgments and reactions.&nbsp; The most appropriate approach is to conceptualize the patient&#39;s behavior in a family context and to recommend <strong>family therapy</strong> with the goal of <strong>improving communication</strong> between the patient and his parents and <strong>resolving family conflict</strong>.&nbsp; Rather than pathologizing the adolescent as the identified patient, this approach is a means of helping the entire family improve their communication and conflict resolution skills and develop mutual understanding and respect.</p><p>Family therapy is conducted by a trained family therapist and focuses on changing dysfunctional patterns of interaction among family members to enhance family functioning.&nbsp; The therapist can help family members resolve disagreements about rules and expectations and develop strategies to defuse escalating arguments.&nbsp; Family therapy has been shown to increase positive outcomes in adolescent behavioral problems, substance use disorders, and depression.</p><p><strong>(Choice A)</strong>&nbsp; This patient is having significant difficulty communicating with his father.&nbsp; Simply encouraging the patient to communicate more with his father places the burden on the patient to resolve the family dysfunction.&nbsp; In addition, this would likely lead only to the patient and his father reenacting their conflicts.&nbsp; Family therapy, in which a therapist can observe the interactions and facilitate communication between family members, would be more likely to resolve the conflict.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s behavior (eg, avoidance of the father, withdrawal from the family) is not normal, and the current dysfunctional interaction between the patient and his parents is unlikely to improve without therapeutic intervention.</p><p><strong>(Choice D)</strong>&nbsp; Fluoxetine is a selective serotonin reuptake inhibitor indicated for the treatment of moderate to severe pediatric depression.&nbsp; This patient lacks key features of depression (eg, loss of interest, sleep and appetite disturbance, lethargy, suicidality); his change in behavior appears to be in response to a strained relationship with his father.</p><p><strong>(Choice E)</strong>&nbsp; This patient has been open with the physician about his experimentation with marijuana and shows no signs of drug abuse or dependence that would necessitate referral for drug counseling.&nbsp; This approach would mistakenly conceptualize the concern as a substance use issue and fail to address the dysfunctional family dynamics.</p><p><strong>Educational objective:</strong><br>Family therapy is a type of counseling that focuses on changing dysfunctional patterns of interaction among family members to enhance family functioning.&nbsp; It has been shown to increase positive outcomes in adolescent behavioral problems, substance use disorders, and depression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330634,
            "topicAttribute": "Normal behavior and development",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Encourage the patient to communicate more with his father",
                    "choiceNumber": 1,
                    "correctTaken": 1583,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance that the patient&#39;s behaviors are age-appropriate",
                    "choiceNumber": 2,
                    "correctTaken": 4880,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend family therapy",
                    "choiceNumber": 3,
                    "correctTaken": 12646,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend trial of fluoxetine",
                    "choiceNumber": 4,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for drug counseling",
                    "choiceNumber": 5,
                    "correctTaken": 555,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27731494",
                    "mediaDataId": 0,
                    "title": "The effectiveness of functional family therapy for adolescent behavioral and substance misuse problems: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27731494",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26092734",
                    "mediaDataId": 0,
                    "title": "Overview of the evidence base for family interventions in child psychiatry.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26092734",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 65,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 19852,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 355,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 21410,
            "questionIndex": 23098,
            "questionText": "<p>A 44-year-old man comes to the office for routine follow-up.&nbsp; Medical history is significant for mild chronic obstructive pulmonary disease and major depressive disorder.&nbsp; The patient has smoked a half-pack of cigarettes daily for 25 years.&nbsp; He has attempted to quit smoking several times in the past year.&nbsp; He is frustrated by his inability to maintain abstinence for more than a few days, saying, &#x22;I just always go right back to the same thing.&#x22;&nbsp; The patient has recently started taking varenicline and nicotine replacement therapy again.&nbsp; He participates in a social support group whenever his schedule allows and has called the tobacco cessation hotline occasionally.&nbsp; The patient is unsure what triggers his relapse, but he thinks that stress might be a factor.&nbsp; Which of the following counseling strategies is the best next step to promote successful smoking cessation in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T79822\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Smoking cessation interventions by stage of change</strong></p></td></tr><tr><td><p align=\"center\"><strong>Not ready to quit</strong></p></td><td><ul><li>Conduct motivational interviewing (4R): relevance, risks, rewards, roadblocks</li><li>Repeat at every visit</li><li>Prescribe varenicline* to facilitate reduce-to-quit strategy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ready to quit</strong></p></td><td><ul><li>Set a firm quit date &amp; discard smoking paraphernalia</li><li>Provide behavioral counseling &amp; engage support systems</li><li>Prescribe pharmacotherapy (eg, varenicline, bupropion, NRT)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Struggling to quit</strong></p></td><td><ul><li>Reinforce partial achievements</li><li>Identify triggers &amp; link them to other (distracting) activities</li><li>Use biofeedback loops (eg, exhaled CO monitoring, gamification using mobile app)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Recently quit</strong></p></td><td><ul><li>Congratulate &amp; offer continued support</li><li>Continue pharmacotherapy for 12 weeks</li><li>Encourage active reflection (anticipated problems, &#x22;how has your life changed?&#x22;)</li></ul></td></tr><tr><td colspan=\"2\"><p>*2-fold higher rate of durable abstinence.</p><p><strong>CO</strong> = carbon monoxide; <strong>NRT</strong> = nicotine replacement therapy.</p></td></tr></tbody></table></div><p><strong>Tobacco addiction</strong> encompasses physical nicotine dependency (eg, withdrawal, cravings), psychological reliance (eg, smoking to relieve stress), and habitual behavior (eg, automatically smoking after a meal).&nbsp; Pharmacotherapy helps alleviate withdrawal (eg, nicotine replacement) and cravings (eg, varenicline, bupropion).&nbsp; However, patients often need <strong>behavioral counseling</strong> and other forms of assistance to address the psychological and habitual motivations to smoke.</p><p>This patient is in the process of smoking cessation.&nbsp; He is action oriented (eg, adherent to pharmacotherapy, participating in support group) but <strong>struggling with early relapses</strong> in part due to stress.&nbsp; In this active stage of change, the physician&#39;s role is to help the patient develop <strong>specific strategies</strong> to quit.</p><p>Most urges to smoke are transient, lasting between 5 and 10 minutes.&nbsp; One of the most powerful behavioral strategies involves identifying the habitual <strong>triggers</strong> (eg, morning coffee, bowel movement, driving) and <strong>linking</strong> them to <strong>alternative, distracting activities</strong> (eg, flossing teeth, chewing gum).&nbsp; Ideally, the patient will propose the alternative activities.&nbsp; This strategy of trigger-behavior linking is even more effective when applied to the <strong>first cigarette of the day</strong>.&nbsp; The ability to delay the time to first cigarette is a strong predictor of success.</p><p><strong>(Choice A)</strong>&nbsp; Listing benefits and drawbacks of smoking is a component of motivational interviewing for patients in the precontemplative and early contemplative stages of change (ie, not ready to quit).&nbsp; This patient is in the action stage; he has already internalized the benefits of smoking cessation but needs behavioral assistance to meet his goal.</p><p><strong>(Choice C)</strong>&nbsp; A firm quit date is a key first step for every cessation attempt.&nbsp; However, this patient has early relapses; missing another quit date will likely lead to disappointment and reinforce his cycle of frustration.</p><p><strong>(Choice D)</strong>&nbsp; Life stressors are nearly universal experiences for patients attempting to quit smoking.&nbsp; A key component of smoking cessation is helping patients manage stress by choosing healthier coping habits.&nbsp; Moreover, having &#x22;minimal&#x22; stress is not a reasonable expectation.</p><p><strong>(Choice E)</strong>&nbsp; Frightening images (eg, oral cancer, blackened lungs) may deter some patients from smoking.&nbsp; Others choose to tape a picture of their children or other loved ones to the cigarette carton.&nbsp; This tactic is rooted in eliciting guilt, which may be effective for deciding to quit acutely.&nbsp; However, it is unlikely to modify trigger responses and habits, which is critical for creating lasting change.</p><p><strong>Educational objective:</strong><br>For patients who are in the active stage of smoking cessation but struggling with relapses, a powerful behavioral strategy is to identify habitual triggers for smoking (especially for the first cigarette of the day) and then link them to alternative distracting activities.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 1704,
            "topic": "Smoking Cessation",
            "titleId": 1704,
            "title": "Smoking Cessation",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ask the patient to list 3 benefits and 3 drawbacks of smoking cessation",
                    "choiceNumber": 1,
                    "correctTaken": 1296,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inquire about the patient&#39;s activities while smoking his first cigarette of the day",
                    "choiceNumber": 2,
                    "correctTaken": 3258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mutually decide on a new quit date and tell the patient to mark it on his calendar",
                    "choiceNumber": 3,
                    "correctTaken": 469,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend delaying smoking cessation until he is under minimal life stress",
                    "choiceNumber": 4,
                    "correctTaken": 69,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urge the patient to tape a picture of his children to the front of the cigarette box",
                    "choiceNumber": 5,
                    "correctTaken": 97,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1118,1229,true,-1,1*199,259,true,-1,1*132,175,true,-1,1*413,440,true,-1,1*493,636,true,-1,1*690,727,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 5189,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2085,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 3379,
            "questionIndex": 3379,
            "questionText": "<p>An 11-year-old boy is brought to the office by his mother due to concerns about his anxiety and adjustment to school.&nbsp; Six months ago, the patient started a new school that requires him to change classrooms for different subjects.&nbsp; The mother says that he has always been shy and had difficulty making friends.&nbsp; She says that the change has been stressful for him and has not become easier over time.&nbsp; The patient reads at grade level and does well in math; however, he has difficulty in classes that require oral participation or group involvement and gets into trouble because he blurts out answers.&nbsp; The patient&#39;s behavior outside school causes problems as well.&nbsp; Last week, when morning traffic required departing from routine by taking a different route to school, he became agitated and threw his school bag, hitting his brother in the face.&nbsp; While the mother is speaking, the patient interrupts to say that he would rather read about astronomy on his own because school is &#x22;a stupid waste of time.&#x22;&nbsp; Physical examination is remarkable for a repetitive opening and closing motion of his hands&mdash;which becomes more intense when he is asked about school&mdash;but is otherwise normal.&nbsp; Which of the following is the most likely explanation for the patient&#39;s behavior?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34848\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Autism spectrum disorder </strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Social deficits with onset in early development<ul style=\"list-style-type:circle;\"><li>Difficulty sharing emotions or interests</li><li>Lack of nonverbal communication (eg, eye contact)</li><li>Difficulty developing/understanding relationships&nbsp;</li></ul></li><li>Restricted, repetitive behaviors &amp; interests<ul style=\"list-style-type:circle;\"><li>Repetitive movements (eg, hand-flapping) or speech</li><li>Insistence on sameness/routines</li><li>Intense, fixated interests</li><li>Adverse responses to sensory input (eg, foods, textures)</li></ul></li><li>&plusmn; Language delays &amp; cognitive impairment&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Comprehensive clinical evaluation</li><li>Genetic testing (eg, chromosomal microarray, fragile X gene analysis)</li><li>&plusmn; Brain MRI (eg, macrocephaly, neurologic deficits)</li></ul></td></tr><tr><td><strong>&nbsp; &nbsp;Management&nbsp;</strong></td><td><ul><li>Behavioral, speech, occupational therapies</li></ul></td></tr><tr><td colspan=\"2\"></td></tr></tbody></table></div><p>This patient has:</p><ul><li>difficulty navigating social interactions (difficulty making friends, struggles in group activities, and interrupting others).</li><li>inability to tolerate changes in routine (changing classrooms and alternate school routes).</li><li>repetitive movements (opening and closing his hands).</li></ul><p>These features are suggestive of <strong>autism spectrum disorder</strong> (ASD).</p><p>Patients with <strong>milder</strong> autism frequently have normal or near-normal language and intellectual ability that may lead to a <strong>delay in diagnosis</strong> (whereas more severe ASD is usually diagnosed by age 5).&nbsp; However, as social expectations increase <strong>with age</strong>, deficits in social awareness and interpersonal skills become <strong>more noticeable</strong>.</p><p>Concerning features include inability to interpret and respond appropriately to nonverbal cues; abnormal eye contact; intense, perseverative interests or one-sided conversations; difficulties understanding sarcasm, metaphors, or humor; and abnormal sensory sensitivity.&nbsp; In addition, <strong>changes in routines</strong> commonly cause anxiety and can provoke agitation or behavioral dysregulation (such as this patient&#39;s bag throwing).</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s social deficits have become more apparent with the increased demands of his new school.&nbsp; Stressors often exacerbate the symptoms of a preexisting condition; however, his difficulties are preexisting manifestations of ASD (always had difficulty making friends) and not simply a time-limited response to a stressor as seen in adjustment disorder.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s blurting out of answers is likely due to difficulty interpreting and responding appropriately to social cues.&nbsp; He does not display multiple symptoms of hyperactivity, impulsivity, and/or impaired attention in multiple settings to warrant a separate diagnosis of attention deficit hyperactivity disorder.</p><p><strong>(Choice D)</strong>&nbsp; Patients with obsessive-compulsive disorder (OCD) can also present with rigid adherence to specific routines.&nbsp; However, this patient lacks the intrusive obsessional thoughts and corresponding compulsive rituals characteristic of OCD.</p><p><strong>(Choice E)</strong>&nbsp; This patient&#39;s outbursts are a response to difficulty tolerating change or navigating social cues.&nbsp; He does not display the pattern of willful disregard for authority or vindictiveness seen in oppositional defiant disorder.</p><p><strong>(Choice F)</strong>&nbsp; Tourette syndrome is characterized by multiple motor and vocal tics, often with premonitory urge, which can worsen with stress.&nbsp; However, this patient&#39;s motor stereotypy helps him self-soothe during distressing thoughts about school.&nbsp; Furthermore, social deficits and insistence on routine are not consistent with Tourette syndrome.</p><p><strong>Educational objective:</strong><br>Autism spectrum disorder is characterized by social deficits, behavioral rigidity with resistance to change, and repetitive movements.&nbsp; Onset is in early development; however, patients with normal language and intellectual ability may be diagnosed later, when social demands make deficits more apparent.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24211,
            "topic": "Autism spectrum disorders",
            "titleId": 24211,
            "title": "Autism spectrum disorders",
            "topicAttributeId": 331288,
            "topicAttribute": "Neurodevelopmental and neurocognitive disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 464,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attention deficit hyperactivity disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2069,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autism spectrum disorder",
                    "choiceNumber": 3,
                    "correctTaken": 11094,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 5,
                    "correctTaken": 381,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tourette syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 2052,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34275441",
                    "mediaDataId": 0,
                    "title": "Behavioural and physiological response to frustration in autistic youth: associations with irritability.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34275441",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29082426",
                    "mediaDataId": 0,
                    "title": "Anxiety disorders and obsessive-compulsive disorder in individuals with autism spectrum disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29082426",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32793002",
                    "mediaDataId": 0,
                    "title": "Social anxiety in children and adolescents with autism spectrum disorders contribute to impairments in social communication and social motivation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32793002",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16916,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1896,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 11006,
            "questionIndex": 12145,
            "questionText": "<p>A 46-year-old man is hospitalized due to suicidal ideation and hearing voices.&nbsp; The patient has become increasingly depressed over the past month and has been unable to work.&nbsp; Last week he told his wife that he was &#x22;tormented by voices&#x22; and that &#x22;death would be a relief.&#x22;&nbsp; She brought him to the hospital after she found him staring at a blank screen on the television and not responding to her questions.&nbsp; The patient was prescribed risperidone, lithium, and escitalopram by his psychiatrist, but his wife is unsure if he takes them regularly.&nbsp; He has a history of bipolar disorder since age 18 with multiple hospitalizations for both manic and depressive episodes.&nbsp; His other medical problems are hypercholesterolemia and seasonal allergies.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 125/80 mm Hg, pulse is 68/min, and respirations are 12/min.&nbsp; Routine laboratory results are within normal limits, lithium level is within therapeutic range, and a toxicology screen is negative.&nbsp; During the evaluation, the patient stares blankly and is mute and motionless.&nbsp; He resists all instructions to move.&nbsp; When the physician lifts the patient&#39;s arm, it remains in the exact same position after she lets go.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39673\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Catatonia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Immobility or excessive purposeless activity&nbsp;</li><li>Mutism, stupor (decreased alertness &amp; response to stimuli)</li><li>Negativism (resistance to instructions &amp; movement)</li><li>Posturing (assuming positions against gravity)</li><li>Waxy flexibility (initial resistance, then maintenance of new posture)</li><li>Echolalia, echopraxia (mimicking speech &amp; movements)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Benzodiazepines (lorazepam)</li><li>Electroconvulsive therapy</li></ul></td></tr></tbody></table></div><p>This patient&#39;s history of severe bipolar disorder and current <strong>immobility</strong> and <strong>mutism</strong> are suggestive of <strong>catatonia</strong>.&nbsp; Catatonia is a syndrome (not a specific disorder) of marked psychomotor disturbance that occurs in severely ill patients with mood disorders with psychotic features, psychotic disorders, autism spectrum disorder, and medical conditions (infectious, metabolic, neurologic, rheumatologic).&nbsp; Common features include decreased motor activity, lack of responsiveness during interview, <strong>posturing</strong>, and waxy flexibility (initial resistance to repositioning by the examiner, followed by maintenance of new repositioned posture).&nbsp; Catatonia can range from stupor to marked agitation (catatonic excitement), which contributes to difficulty in recognition.</p><p>Treatment of catatonia includes <strong>benzodiazepines</strong>&nbsp;(most commonly lorazepam) and/or <strong>electroconvulsive therapy (ECT)</strong>.&nbsp; A <strong>lorazepam</strong> challenge test (intravenous lorazepam 1-2 mg) resulting in partial, temporary relief within 5-10 minutes confirms the diagnosis.&nbsp; Catatonia generally responds to lorazepam within a week; ECT is the treatment of choice in patients who do not improve.</p><p><strong>(Choice A)</strong>&nbsp; Benztropine is an anticholinergic medication used to treat extrapyramidal side effects (eg, acute dystonic reaction, parkinsonism) of antipsychotic medications.&nbsp; This patient&#39;s complete immobility, mutism with lack of responsiveness, and waxy flexibility are more characteristic of catatonia.</p><p><strong>(Choices B and E)</strong>&nbsp; Antipsychotics can worsen catatonia and should be avoided.&nbsp; Clozapine is generally reserved for treatment-refractory psychosis due to the risk of severe neutropenia.&nbsp; Treatment of this patient&#39;s underlying bipolar disorder with risperidone should be deferred until his catatonia resolves with lorazepam.</p><p><strong>(Choice C)</strong>&nbsp; The serotonin antagonist cyproheptadine has been used to treat severe cases of serotonin syndrome, which is characterized by a triad of autonomic instability, altered mental status, and neuromuscular irritability.</p><p><strong>(Choice D)</strong>&nbsp; Dantrolene has been used to treat muscular rigidity associated with severe neuroleptic malignant syndrome that does not respond to discontinuation of antipsychotic medication.&nbsp; This syndrome is characterized by fever, diffuse muscular rigidity, autonomic instability, and significant laboratory abnormalities (eg, elevated creatine kinase).&nbsp; It is unlikely in this patient, who has stable vital signs.</p><p><strong>Educational objective:</strong><br>Catatonia is a syndrome seen in severe psychiatric and medical illness and is characterized by immobility, mutism, and posturing.&nbsp; Lorazepam and electroconvulsive therapy are the treatments of choice.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 5953,
            "topic": "Catatonia",
            "titleId": 5953,
            "title": "Catatonia",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "6",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Benztropine",
                    "choiceNumber": 1,
                    "correctTaken": 5011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clozapine",
                    "choiceNumber": 2,
                    "correctTaken": 2380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyproheptadine",
                    "choiceNumber": 3,
                    "correctTaken": 752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dantrolene",
                    "choiceNumber": 4,
                    "correctTaken": 1203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase risperidone",
                    "choiceNumber": 5,
                    "correctTaken": 1603,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 6,
                    "correctTaken": 7570,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29398916",
                    "mediaDataId": 0,
                    "title": "Systematic review of catatonia treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29398916",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28640169",
                    "mediaDataId": 0,
                    "title": "The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28640169",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25538636",
                    "mediaDataId": 0,
                    "title": "A clinical review of the treatment of catatonia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25538636",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 18519,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 2661,
            "questionIndex": 2661,
            "questionText": "<p>A 46-year-old man is admitted to the hospital due to cellulitis of the right hand.&nbsp; He has a history of intravenous drug use, alcohol use disorder, and septic arthritis of the knee.&nbsp; Treatment with vancomycin is initiated.&nbsp; The day after admission, the cellulitis has improved; however, the patient now reports that he sees bats flying around his room.&nbsp; He says that he has never before experienced visual hallucinations.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 131/89 mm Hg, pulse is 93/min, and respirations are 18/min.&nbsp; Examination shows decreased swelling and redness of the right hand, mild tremors bilaterally, and diaphoresis.&nbsp; The patient is alert and oriented but appears frightened.&nbsp; Which of the following is the most appropriate next step in management at this time?</p>",
            "questionHeader": "",
            "explanationText": "<p>The abrupt onset of hallucinations in this patient with a known history of alcohol use disorder and classic signs of alcohol withdrawal (eg, tremors, diaphoresis) after a period of forced abstinence (ie, admission to the hospital) is consistent with <a href=\"2109\">alcoholic hallucinosis</a>.&nbsp; Alcoholic hallucinosis usually presents <strong>within 24 hours</strong> of the last drink and most commonly causes <strong>visual hallucinations</strong> (eg, bats flying around the room), although tactile and auditory hallucinations are also possible.</p><p>Patients with alcoholic hallucinosis are typically alert, with intact cognition and awareness, despite the presence of distressing hallucinations.&nbsp; In contrast, patients with delirium tremens (DT) typically have confusion and disorientation with severe autonomic hyperactivity (eg, high fever, hypertension); hallucinations in DT typically occur &gt;48 hours after the last drink.</p><p>Patients with alcohol withdrawal should be treated with <strong>benzodiazepines</strong> (eg, lorazepam) to control symptoms and <strong>prevent progression of withdrawal</strong> (eg, seizures, DT), which can be life-threatening.&nbsp; DT is associated with a mortality rate as high as 5% <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Antipsychotics such as haloperidol are not indicated for the treatment of alcoholic hallucinosis, which resolves with treatment of the underlying alcohol withdrawal.&nbsp; Antipsychotics may lower the seizure threshold and should be avoided in the seizure-prone state of alcohol withdrawal.</p><p><strong>(Choice C)</strong>&nbsp; Adverse effects of vancomycin include ototoxicity, vancomycin infusion reaction (a pseudoallergic reaction characterized by flushing and pruritus), and nephrotoxicity.&nbsp; Vancomycin is improving this patient&#39;s infection and is not causing his symptoms.</p><p><strong>(Choice E)</strong>&nbsp; This patient has no localizing signs or symptoms that suggest a neurologic lesion and exhibits classic signs of alcohol withdrawal.&nbsp; CT scan of the head is not indicated unless withdrawal treatment fails to resolve his symptoms or new neurologic deficits develop.</p><p><strong>Educational objective:</strong><br>Alcoholic hallucinosis usually presents within 24 hours after the last drink and is typically associated with other symptoms of alcohol withdrawal (eg, tremor, diaphoresis).&nbsp; Treatment consists of benzodiazepines to control symptoms and prevent the progression of withdrawal.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 16983,
            "topic": "Alcohol withdrawal",
            "titleId": 16983,
            "title": "Alcohol withdrawal",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer haloperidol",
                    "choiceNumber": 1,
                    "correctTaken": 1380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administer lorazepam",
                    "choiceNumber": 2,
                    "correctTaken": 2069,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue vancomycin",
                    "choiceNumber": 3,
                    "correctTaken": 995,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional intervention needed",
                    "choiceNumber": 4,
                    "correctTaken": 157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a CT scan of the head",
                    "choiceNumber": 5,
                    "correctTaken": 442,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27196747",
                    "mediaDataId": 0,
                    "title": "Management of acute alcohol withdrawal syndrome in critically ill patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27196747",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26500991",
                    "mediaDataId": 0,
                    "title": "Alcohol withdrawal syndrome: benzodiazepines and beyond.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26500991",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 134,
            "othersAvgTimeSpent": 42,
            "notes": null,
            "peopleTaken": 5043,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 11277,
            "questionIndex": 12432,
            "questionText": "<p>A 55-year-old woman comes to the office due to insomnia and fatigue that began shortly after her divorce was finalized a year ago.&nbsp; The patient used to sleep 7-8 hours without difficulty; however, over the past year she has had increasing difficulty falling asleep and started drinking 2-3 glasses of wine before bedtime to help.&nbsp; Despite falling asleep more quickly, she has recently started to regularly wake up around 3:00 AM.&nbsp; Her symptoms have progressively worsened and she now lies awake for several hours in the middle of the night, thinking and worrying about her future, but she rarely experiences anxiety during the day.&nbsp; She reports mild difficulty with concentration and no change in appetite.&nbsp; The patient experiences occasional brief sadness and loneliness.&nbsp; She has recently started showing up late for work and has stopped attending her weekly exercise class.&nbsp; Medical history includes hypothyroidism, treated with levothyroxine, and gastroesophageal reflux disease, diagnosed 3 months ago and treated with famotidine.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 140/90 mm Hg, pulse is 90/min, and respirations are 12/min.&nbsp; Physical examination shows a mild tremor but no other abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>11.4 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>34%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>106 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>150,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>142 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.9 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>102 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>26 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>20 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total protein</td><td>6.5 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>0.7 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>78 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>85 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>42 U/L</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Endocrine</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;TSH</td><td>2.7 &micro;U/mL</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>The National Institute on Alcohol Abuse and Alcoholism has found evidence of negative health effects for women of all ages and men age &#8805;65 who consume &gt;7 drinks in a week or &gt;3 in a day (for men age &lt;65, the cutoffs are &gt;14 drinks in a week or &gt;4 drinks in a day).&nbsp; This patient&#39;s alcohol consumption pattern (&#8805;14 drinks per week), abnormal liver enzymes (<strong>aspartate aminotransferase/alanine aminotransferase ratio &#8805;2:1</strong>), <strong>macrocytosis</strong>, alcohol tolerance (ie, decreasing sedative effects of alcohol over time), and impaired functioning (eg, work tardiness) are consistent with a diagnosis of <strong>alcohol use disorder</strong>.&nbsp; This diagnosis is also supported by her history of gastroesophageal reflux disease and hypertension as well as a tremor on examination.</p><p>Individuals with alcohol use disorder frequently seek primary care due to <strong>sleep disturbance</strong> and/or <strong>anxiety</strong> symptoms from <strong>mild withdrawal</strong>, as in this patient.&nbsp; These individuals may use alcohol to fall asleep, but as the blood alcohol level drops, CNS hyperarousal occurs and results in awakenings.</p><p><strong>(Choice A)</strong>&nbsp; Although this patient&#39;s alcohol use may have initially escalated in response to her divorce a year ago, adjustment disorder cannot be diagnosed in a patient whose symptoms have lasted &gt;6 months after a stressor.</p><p><strong>(Choice C)</strong>&nbsp; There is insufficient evidence that this patient&#39;s insomnia and anxiety are a direct result of the physiological effects of a medical condition.&nbsp; Her normal TSH level indicates that her hypothyroidism is well controlled.</p><p><strong>(Choice D)</strong>&nbsp; Generalized anxiety disorder is characterized by pervasive and excessive worry about multiple issues and is typically seen in patients who report lifelong anxiety.&nbsp; It is less likely in this patient with signs/symptoms of alcohol use disorder, no history of psychiatric illness, and circumscribed anxiety (ie, only worries at night when unable to sleep).</p><p><strong>(Choice E)</strong>&nbsp; Although this patient may have initially developed difficulty falling asleep in the context of a divorce, it developed into a classic pattern of alcohol-induced sleep disruption with the onset of heavy drinking.&nbsp; Insomnia disorder is diagnosed only when the sleep disturbance is not better explained by another disorder.</p><p><strong>(Choice F)</strong>&nbsp; A diagnosis of dysthymia would require a depressed mood for at least 2 years and substance-induced causes to be ruled out.</p><p><strong>Educational objective:</strong><br>Patients with unhealthy alcohol use are frequently seen in the primary care setting for insomnia and/or anxiety.&nbsp; These patients should be carefully screened for alcohol use disorder.&nbsp; Findings of increased liver enzymes and macrocytosis can also assist in screening.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24408,
            "topic": "Alcohol use disorder",
            "titleId": 24408,
            "title": "Alcohol use disorder",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcohol use disorder",
                    "choiceNumber": 2,
                    "correctTaken": 11432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anxiety disorder due to another medical condition",
                    "choiceNumber": 3,
                    "correctTaken": 1729,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 980,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insomnia disorder",
                    "choiceNumber": 5,
                    "correctTaken": 2304,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 6,
                    "correctTaken": 1544,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27706838",
                    "mediaDataId": 0,
                    "title": "Alcohol dependence and its relationship with insomnia and other sleep disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27706838",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23631601",
                    "mediaDataId": 0,
                    "title": "Screening for substance abuse in women&#39;s health:  a public health imperative.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23631601",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22553426",
                    "mediaDataId": 0,
                    "title": "Screening for alcohol and drug use disorders among adults in primary care:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22553426",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 191,
            "othersAvgTimeSpent": 104,
            "notes": null,
            "peopleTaken": 19197,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 13706,
            "questionIndex": 15096,
            "questionText": "<p>A 32-year-old man comes to the office due to recent insomnia.&nbsp; The patient has experienced stress at his job in the past month because he has had to work extra hours on multiple occasions while several coworkers have been on vacation or sick.&nbsp; Over the past 2 weeks, he has had difficulty falling asleep most nights and has been fatigued throughout the day.&nbsp; Recently, the patient has started drinking 1 or 2 beers at night to help him fall asleep as well as energy drinks throughout the day to stay alert.&nbsp; He describes feeling anxious and irritable and has experienced occasional palpitations and feelings of panic.&nbsp; The patient has a history of depression.&nbsp; He does not use illicit drugs.&nbsp; Blood pressure is 140/90 mm Hg and pulse is 95/min.&nbsp; On examination, the patient is restless and mildly tremulous with a flushed and agitated appearance, irritable mood, and rapid speech.&nbsp; Which of the following is the most likely explanation for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s insomnia, anxiety, palpitations, hypertension, and tremulousness are suggestive of <strong>caffeine intoxication</strong>, likely due to his recent excessive consumption of <strong>energy drinks</strong>.&nbsp; Energy drinks frequently contain high quantities of caffeine and may lead to toxicity when consumed in excess.</p><p>Caffeine is a stimulant that, when used excessively, can result in <strong>insomnia</strong>, <strong>jitteriness</strong>, <strong>anxiety</strong>, gastrointestinal symptoms, and headaches, as well as more serious adverse effects including tachycardia, hypertension, <strong>panic attacks</strong>, <strong>agitation</strong>, psychosis, and seizures.&nbsp; Energy drink consumption is especially popular among adolescents and young men, and it should be considered in anyone with signs or symptoms of stimulant intoxication.</p><p><strong>(Choices A and F)</strong>&nbsp; Adjustment and primary anxiety (eg, panic) disorders are diagnoses of exclusion that would not be diagnosed when symptoms are more likely to be substance-induced.</p><p><strong>(Choice B)</strong>&nbsp; Alcohol withdrawal can also result in anxiety, insomnia, tremulousness, hypertension, and palpitations.&nbsp; However, it is usually associated with heavy drinking and other signs of dependence.&nbsp; The amount that this patient is drinking would be very unlikely to lead to withdrawal; furthermore, his history is more consistent with caffeine intoxication from energy drinks.</p><p><strong>(Choice D)</strong>&nbsp; Although covering several different shifts at work could explain this patient&#39;s insomnia, it would not explain his daytime anxiety, restlessness, tremors, or palpitations, which are more consistent with caffeine intoxication.</p><p><strong>(Choice E)</strong>&nbsp; A hypomanic episode can include insomnia, irritability, and pressured speech, but this patient lacks other characteristic hypomanic symptoms (eg, elevated mood, increased energy, grandiosity).&nbsp; It would not explain this patient&#39;s prominent signs of sympathetic stimulation.</p><p><strong>Educational objective:</strong><br>Caffeine is a stimulant that, when used in excessive amounts, can cause sympathetic hyperactivity, leading to anxiety, jitteriness, insomnia, palpitations, and tremors.&nbsp; Energy drinks typically contain large amounts of caffeine and should be considered as a cause of stimulant intoxication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24386,
            "topic": "Stimulants",
            "titleId": 24386,
            "title": "Stimulants",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 2,
                    "correctTaken": 1171,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Caffeine intoxication",
                    "choiceNumber": 3,
                    "correctTaken": 10405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Circadian sleep-wake rhythm disorder, shift work type",
                    "choiceNumber": 4,
                    "correctTaken": 1132,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypomanic episode",
                    "choiceNumber": 5,
                    "correctTaken": 1869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 6,
                    "correctTaken": 294,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30505695",
                    "mediaDataId": 0,
                    "title": "The clinical toxicology of caffeine: a review and case study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30505695",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28845841",
                    "mediaDataId": 0,
                    "title": "Caffeinated energy drink consumption among adolescents and potential health consequences associated with their use: a significant public health hazard.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28845841",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25560302",
                    "mediaDataId": 0,
                    "title": "Energy drinks and their adverse health effects: a systematic review of the current evidence.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25560302",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 140,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16056,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 10759,
            "questionIndex": 11887,
            "questionText": "<p>An 11-year-old girl is brought to the office by her father after getting suspended from her new school for pushing a peer while waiting in line at the cafeteria.&nbsp; There has been a history of behavioral concerns since first grade, and the parents have received occasional calls home from the teacher for talking back and refusing to stay in her seat.&nbsp; Her father reports that the patient has always had a lot of energy and &#x22;needs to be active to stay out of trouble.&#x22;&nbsp; The patient requires frequent prompting to complete homework assignments and forgets to do her chores.&nbsp; The father states, &#x22;My daughter doesn&#39;t think before she speaks or acts, but this is the first really bad thing she has done.&nbsp; Her dog died last month, and she&#39;s been pretty upset.&#x22;&nbsp; Family history is significant for bipolar disorder in her mother.&nbsp; On examination, the patient is mildly restless and talkative.&nbsp; She says her mood is &#x22;fine&#x22; except for missing her dog and that she &#x22;hates school because it&#39;s so boring.&#x22;&nbsp; Which of the following is the most appropriate statement?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34623\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Attention deficit hyperactivity disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Inattentive &amp;/or hyperactive/impulsive symptoms for &#8805;6 months<ul style=\"list-style-type:circle;\"><li><strong>Inattentive symptoms:</strong> difficulty focusing, distractible, does not listen or follow instructions, disorganized, forgetful, loses/misplaces objects</li><li><strong>Hyperactive/impulsive symptoms:</strong> fidgety, unable to sit still, &#x22;driven by a motor,&#x22; hypertalkative, interrupts, blurts out answers</li></ul></li><li>Several symptoms present <strong>before age 12</strong></li><li>Symptoms occur in at least 2 settings (home, school) &amp; cause functional impairment</li><li>Subtypes: predominantly inattentive, predominantly hyperactive/impulsive, combined type</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Stimulants (methylphenidate, amphetamines)</li><li>Nonstimulants (atomoxetine, &#945;-2 adrenergic agonists)</li><li>Behavioral therapy</li></ul></td></tr></tbody></table></div><p>The description of this child&#39;s behavior is suggestive of <strong>attention deficit hyperactivity disorder</strong> (ADHD).</p><p>Symptoms of ADHD are present across &#8805;2 settings (ie, home, school) and include <strong>inattentive</strong> features (eg, forgetting chores, trouble completing tasks without repeated prompting) and <strong>hyperactive/impulsive</strong> characteristics (eg, unable to sit still, not thinking before reacting).&nbsp; In some children, <strong>unmanaged</strong> symptoms can <strong>escalate to outbursts of frustration</strong> (eg, pushing a peer), as in this case.&nbsp; Structured behavioral observations of symptoms obtained via teacher and parent rating scales support the diagnosis.</p><p><strong>Stimulants</strong> (eg, methylphenidates, amphetamines) are the <strong>first-line treatment</strong> of ADHD in <strong>school-aged</strong> children and adolescents due to their rapid onset of action, effectiveness, and tolerability.&nbsp; As core ADHD symptoms improve with stimulants, impulsive outbursts, academic productivity, and parent-child interactions generally improve as well.&nbsp; Common adverse effects include insomnia or appetite suppression, which can be addressed by adjusting the timing of dose administration (eg, morning/after breakfast).</p><p><strong>(Choice A)</strong>&nbsp; ADHD is a chronic neurodevelopmental disorder, and most symptoms manifest through adolescence into adulthood.&nbsp; This patient&#39;s symptoms are causing impairment and are not expected to spontaneously remit.</p><p><strong>(Choice C)</strong>&nbsp; Sudden or new stressors (eg, pet dying, starting a new school) can lead to mood and behavioral changes in children.&nbsp; However, this patient&#39;s long-standing history of hyperactive/impulsive symptoms with recent worsening behavior suggests a chronic, unmanaged condition (ie, ADHD).</p><p><strong>(Choice D)</strong>&nbsp; Behavioral therapy (eg, parent management training) is an adjunct in ADHD treatment, but this intervention alone does not sufficiently manage core ADHD symptoms in school-aged children and adolescents, for whom stimulants are first-line.&nbsp; Behavioral therapy is also used to treat conduct disorder, which can manifest with conflicts with others, but this patient lacks the characteristic exploitative behaviors reflecting a disregard for others.&nbsp; Moreover, her behavioral concerns appear to be related to impulsivity, a finding consistent with ADHD.</p><p><strong>(Choice E)</strong>&nbsp; Mania in bipolar disorder (eg, increased energy, distractibility) is typically episodic, occurring in distinct periods (eg, 1 week at a time).&nbsp; Although this patient has a positive family history and is described as talkative and energetic, the persistent and nonepisodic nature of her symptoms suggests an alternate diagnosis.</p><p><strong>Educational objective:</strong><br>Stimulants are the first-line treatment for attention deficit hyperactivity disorder in school-aged children.&nbsp; The presentation includes inattentive features (eg, forgetfulness) and hyperactive/impulsive symptoms (eg, excessively energetic) that may escalate into outbursts of frustration when untreated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 4417,
            "topic": "Attention deficit hyperactivity disorder",
            "titleId": 4417,
            "title": "Attention deficit hyperactivity disorder",
            "topicAttributeId": 331288,
            "topicAttribute": "Neurodevelopmental and neurocognitive disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Let&#39;s see how she does over the next year; most children outgrow these behaviors by adolescence and do not require treatment.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 367,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;She seems to have difficulty with focus and impulse control, which is likely due to a disorder for which there are very effective medications.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 10991,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Starting at a new school and losing a pet can be difficult for many children; she is likely experiencing an adjustment period that does not require medication.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 1187,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;There are no medications that have been proved effective for your daughter&#39;s aggression, although a parent-child therapy program may improve her behavior.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 313,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your daughter&#39;s behavior may be a sign of early-onset bipolar disorder; fortunately, this is highly treatable with medication.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 1715,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26601963",
                    "mediaDataId": 0,
                    "title": "Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26601963",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25369623",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of ADHD in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25369623",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 14573,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 10733,
            "questionIndex": 11853,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 21 years<br><strong>Gender:</strong> M, self-identified<br><strong>Site of Care:</strong> emergency department</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> seizure<br><strong>History of Present Illness:</strong></p><ul><li>brought by ambulance after a witnessed seizure 30 minutes ago</li><li>history obtained from his family</li><li>just returned from a party with friends and was &#x22;not acting like himself&#x22; prior to the seizure</li></ul><p><strong>Past Medical History:</strong></p><ul><li>major depressive disorder</li><li>no previous seizures</li></ul><p><strong>Medications:</strong></p><ul><li>sertraline</li></ul><p><strong>Allergies:</strong></p><ul><li>no known drug allergies</li></ul><p><strong>Family History:</strong></p><ul><li>noncontributory</li></ul><p><strong>Psychosocial History:</strong></p><ul><li>is a college student</li><li>occasionally drinks beer</li><li>does not use tobacco</li><li>recreational drug use unknown</li></ul><p><u><strong>Physical Examination</strong></u></p><div class=\"equation-scroll\"><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"min-width:450px;\"><tbody><tr><td style=\"vertical-align: middle; text-align: center;\"><strong>Temp</strong></td><td style=\"vertical-align: middle; text-align: center;\"><strong>Pulse</strong></td><td style=\"vertical-align: middle; text-align: center;\"><strong>Resp</strong></td><td style=\"vertical-align:middle;\"><strong>BP</strong></td><td style=\"vertical-align: middle; text-align: center;\"><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td style=\"text-align: center;\"><strong>Ht</strong></td><td style=\"text-align: center;\"><strong>Wt</strong></td><td style=\"vertical-align: middle; text-align: center;\"><strong>BMI</strong></td></tr><tr><td style=\"vertical-align: middle; text-align: center;\">40 C<br>(104 F)</td><td style=\"vertical-align: middle; text-align: center;\">120/min</td><td style=\"vertical-align: middle; text-align: center;\">16/min</td><td style=\"vertical-align: middle; text-align: center;\">170/96<br>mm Hg</td><td style=\"vertical-align: middle; text-align: center;\">98%<br>on RA</td><td>&ndash;</td><td>&ndash;</td><td style=\"vertical-align:middle;\">23 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table></div><ul><li>Appearance: flushed; diaphoretic</li><li>Pulmonary: clear lungs</li><li>Cardiac: tachycardic with regular rhythm; normal S1 and S2</li><li>Abdominal: increased bowel sounds; soft and nontender; no hepatosplenomegaly</li><li>Neurologic: deep tendon reflexes are 3+ and symmetric in all extremities; spontaneous myoclonus in the upper extremities; minimally responsive to painful stimuli</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">48%</td></tr><tr><td style=\"vertical-align:middle;\">Na<font size=\"2\"><sup>+</sup></font></td><td style=\"vertical-align:middle;\">122 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">K<font size=\"2\"><sup>+</sup></font></td><td style=\"vertical-align:middle;\">3.6 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Cl<font size=\"2\"><sup>&#8722;</sup></font></td><td style=\"vertical-align:middle;\">98 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">HCO<font size=\"2\"><sub>3</sub></font><font size=\"2\"><sup>&#8722;</sup></font></td><td style=\"vertical-align:middle;\">20 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">90 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">1.0 mg/dL</td></tr></tbody></table><ul><li>CT scan of the head: no acute infarction, hemorrhage, or mass lesion</li></ul><p><u><strong>Question:</strong></u> Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t62572\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.25in;\"><strong>Intoxication syndromes in drugs of abuse </strong></p></td></tr><tr><td><p align=\"center\"><strong>Drug</strong></p></td><td><p align=\"center\" style=\"margin-left:.25in;\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>NMDA antagonists<br />(eg, PCP, ketamine)</strong></p></td><td><ul><li>Violent behavior</li><li>Dissociation</li><li>Hallucinations</li><li>Amnesia</li><li>Nystagmus (horizontal or vertical)</li><li>Ataxia</li></ul></td></tr><tr><td><p align=\"center\"><strong>MDMA (ecstasy)</strong></p></td><td><ul><li>Euphoria</li><li>Tachycardia/hypertension</li><li>Hyperthermia</li><li>Serotonin toxicity</li><li>Hyponatremia</li><li>Seizures</li><li>Mydriasis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Benzodiazepines</strong></p></td><td><ul><li>CNS depression</li><li>Normal vital signs</li><li>Slurred speech</li><li>Ataxia</li><li>Coma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Opioid narcotics<br />(eg,</strong><strong>oxycodone)</strong></p></td><td><ul><li>Euphoria</li><li>Depressed mental status</li><li>Respiratory depression</li><li>Miosis</li><li>Constipation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MDMA</strong>&nbsp;=&nbsp;3,4-methylenedioxymethamphetamine;<br /><strong>NMDA</strong>&nbsp;=&nbsp;N-methyl-D-aspartate<strong>; PCP</strong>&nbsp;=&nbsp;phencyclidine.</p></td></tr></tbody></table></div><p>This patient&#39;s presentation suggests <strong>MDMA</strong> intoxication complicated by serotonin syndrome.&nbsp; MDMA, formulated as <strong>ecstasy</strong> or Molly, has mild hallucinogenic properties and is sometimes used by college students during parties to cause <strong>euphoria</strong> and increase <strong>sociability</strong>, alertness, empathy, and <strong>sexual desire</strong>.</p><p>MDMA is a <strong>synthetic amphetamine</strong> that exerts its effects by <strong>increasing</strong> synaptic levels of <strong>norepinephrine</strong>, dopamine, and <strong>serotonin</strong>.&nbsp; Severe <strong>intoxication</strong> may manifest with features of:</p><ul><li><p><strong>sympathomimetic toxicity:</strong> hypertension, tachycardia, diaphoresis, and hyperthermia.</p></li><li><p>serotonin toxicity: <a href=\"973\">serotonin syndrome</a> (eg, altered mental status, hyperreflexia, myoclonus, seizures) and <strong>hyponatremia</strong> (due to drug-induced inappropriate antidiuretic hormone secretion as well as excessive water intake to reduce hyperthermia).</p></li></ul><p>Combining MDMA with other serotonergic drugs (eg, sertraline), as in this patient, further increases the risk of serotonin syndrome.&nbsp; Coma and death may result from acute intoxication, and long-term use has been linked to neurotoxicity.&nbsp; Recreational synthetic amphetamines and analogues (eg, MDMA, bath salts) may not show up as amphetamines in routine urine toxicology screens.</p><p><strong>(Choice A)</strong>&nbsp; Symptoms of alcohol withdrawal may include tachycardia, hypertension, diaphoresis, delirium, and seizures, but myoclonus is not expected.&nbsp; In addition, this patient drinks alcohol only occasionally, making withdrawal less likely.</p><p><strong>(Choice B)</strong>&nbsp; Cannabis intoxication can cause tachycardia and hypertension but typically not hyperthermia; neurologic manifestations (eg, slurred speech and ataxia) may also result, but seizures, myoclonus, or hyperreflexia are usually not seen.</p><p><strong>(Choice C)</strong>&nbsp; Diphenhydramine overdose leading to <a href=\"3444\">anticholinergic toxicity</a> can cause bizarre behavior, flushing, hyperthermia, tachycardia, hypertension, and seizures.&nbsp; However, affected patients typically have anhidrosis and decreased bowel sounds, whereas this patient is diaphoretic with increased bowel sounds.</p><p><strong>(Choice E)</strong>&nbsp; Nitrous oxide is an inhalant sometimes misused for its euphoric and calming properties.&nbsp; It can cause loss of consciousness and seizures (with significant overdoses), but elevated vital signs, myoclonus, hyperreflexia, and hyponatremia are not expected.&nbsp; In addition, its effects typically last only 15-45 minutes.</p><p><strong>(Choice F)</strong>&nbsp; Phencyclidine (PCP) intoxication most often induces severe agitation, psychosis, and aggressive behavior rather than somnolence.&nbsp; Although seizures can occur with large overdoses, they are not typical.</p><p><strong>Educational objective:</strong><br>MDMA is a synthetic amphetamine that can cause euphoria and increased sociability, empathy, and sexual desire.&nbsp; Because it increases synaptic levels of norepinephrine, dopamine, and serotonin, intoxication may manifest with sympathomimetic toxicity (eg, tachycardia, hypertension) and serotonin syndrome (eg, seizures, myoclonus).&nbsp; Use with other serotonergic drugs greatly increases the risk of serotonin syndrome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24317,
            "topic": "Substance use disorders",
            "titleId": 24317,
            "title": "Substance use disorders",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 1,
                    "correctTaken": 229,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cannabis intoxication",
                    "choiceNumber": 2,
                    "correctTaken": 841,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diphenhydramine overdose",
                    "choiceNumber": 3,
                    "correctTaken": 341,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ecstasy intoxication",
                    "choiceNumber": 4,
                    "correctTaken": 5214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nitrous oxide intoxication",
                    "choiceNumber": 5,
                    "correctTaken": 884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phencyclidine intoxication",
                    "choiceNumber": 6,
                    "correctTaken": 309,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32228243",
                    "mediaDataId": 0,
                    "title": "MDMA interactions with pharmaceuticals and drugs of abuse.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32228243",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 7818,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 9530,
            "questionIndex": 10065,
            "questionText": "<p>A 60-year-old woman comes to the office for follow-up of chronic tension-type headaches.&nbsp; Her headaches have not improved after several trials of medications, including those recommended by a neurologist specializing in the management of headaches.&nbsp; The patient says, &#x22;I&#39;m really not surprised that this last medication didn&#39;t work either.&nbsp; All these drug companies just want to make money.&nbsp; I doubt that anything will help.&#x22;&nbsp; When asked if she would consider pursuing biofeedback, relaxation training, or stress management therapy, she responds, &#x22;There&#39;s no point&mdash;how can I relax or do therapy when my head is pounding?&#x22;&nbsp; The patient&#39;s other medical problems include hypertension and hypercholesterolemia, which are well controlled with medication.&nbsp; She has a history of depression following her divorce in her 40s but was unwilling to take an antidepressant or see a counselor at that time.&nbsp; Which of the following statements is the most appropriate response to this patient&#39;s concerns?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient remains symptomatic despite the best efforts of the physician to treat her with multiple medication trials, and she rejects all recommended nonpharmacological approaches.&nbsp; Such patients believe that no treatment will help and appear not to want to improve.&nbsp; They are often frustrating to manage and can leave the physician feeling angry and manipulated.&nbsp; The understandable tendency to want to refer this patient to another provider or specialist should be avoided <strong>(Choice E)</strong>.</p><p>These patients often have underlying depression but will refuse referral to a psychiatrist.&nbsp; They are needy for attention and unconsciously wish to remain symptomatic so that they can continue to see a physician.&nbsp; The best approach is to <strong>empathize</strong> with them and <strong>attempt to engage</strong> them in a <strong>collaborative plan</strong> in which there is mutual agreement about realistic treatment approaches and <strong>limited expectations</strong>.&nbsp; Empathizing with the patient&#39;s frustration over disappointing outcomes and focusing on alleviation of symptoms rather than a cure is often helpful.</p><p><strong>(Choices A and C)</strong>&nbsp; There is insufficient information on this patient to diagnose depression, and she would likely reject this explanation of her poor response.&nbsp; She has previously rejected counseling and is currently resistant to other treatment approaches; therefore, she is unlikely to agree to counseling at this stage.</p><p><strong>(Choice B)</strong>&nbsp; This statement attempts to confront this patient by pointing out her help-rejecting pattern of behavior.&nbsp; This would likely be perceived as judgmental, resulting in loss of rapport and defensiveness.&nbsp; However, it could be useful as part of a therapeutic intervention by a skilled therapist in the context of structured psychotherapy.</p><p><strong>(Choice F)</strong>&nbsp; The physician has already encouraged the patient to consider nonpharmacological approaches.&nbsp; Rather than continuing to make treatment recommendations that will likely be rejected, the physician should develop a collaborative focus on a small goal that she identifies.</p><p><strong>Educational objective:</strong><br>Help-rejecting patients who are hopeless about treatment can lead the physician to become frustrated and confrontational and to desire to refer the patient to another provider.&nbsp; Clear expression of empathy and a collaborative approach with limited goals are the most effective approaches.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24827,
            "topic": "Physician patient communication",
            "titleId": 24827,
            "title": "Physician patient communication",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "I am concerned that depression is contributing to your hopelessness about getting better.",
                    "choiceNumber": 1,
                    "correctTaken": 222,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "I can see that it has been frustrating, but let&#39;s explore why you seem to reject every new suggestion.",
                    "choiceNumber": 2,
                    "correctTaken": 1075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "I can see that you are feeling hopeless; talking with a counselor may help improve your outlook.",
                    "choiceNumber": 3,
                    "correctTaken": 106,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "I can see that your lack of improvement has been frustrating; let&#39;s identify a small goal we can agree on.",
                    "choiceNumber": 4,
                    "correctTaken": 12057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "I share your frustration; let&#39;s obtain a second opinion from a psychiatrist who may help identify new treatment strategies.",
                    "choiceNumber": 5,
                    "correctTaken": 227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It must be frustrating that medications have not helped; I encourage you to reconsider biofeedback and relaxation training.",
                    "choiceNumber": 6,
                    "correctTaken": 360,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23547575",
                    "mediaDataId": 0,
                    "title": "Managing difficult encounters: understanding physician, patient, and situational factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23547575",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 14047,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 3372,
            "questionIndex": 3372,
            "questionText": "<p>A 42-year-old man is brought to the emergency department by police officers after he was found wandering aimlessly at an airport.&nbsp; The man is alert and answers questions appropriately; however, he appears to be confused about his identity and does not recognize the name on his Nevada driver&#39;s license in his wallet.&nbsp; Extensive inquiry fails to reveal any helpful information as the patient is perplexed and does not remember where he lives, how he got to the airport, his family members, or his profession.&nbsp; His cognitive function is otherwise intact.&nbsp; A search of his personal belongings reveals an airline ticket from Las Vegas to Arlington, Virginia.&nbsp; An emergency contact on the patient&#39;s phone leads to his wife in Nevada, who reports that her husband &#x22;just disappeared&#x22; after he found out that his father had passed away that morning.&nbsp; Physical examination, routine laboratory values, and brain CT scan are unremarkable, and a urine toxicology screen is negative.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39448\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Dissociative disorders</strong></p></td></tr><tr><td><p align=\"center\"><strong>Depersonalization/ derealization disorder</strong></p></td><td><ul><li>Persistent or recurrent experiences of 1 or both:<ul style=\"list-style-type:circle;\"><li>Depersonalization (feelings of detachment from, or being an outside observer of, oneself)</li><li>Derealization (experiencing surroundings as unreal)</li></ul></li><li>Intact reality testing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dissociative amnesia</strong></p></td><td><ul><li>Inability to recall important personal information, usually of a traumatic or stressful nature</li><li>Not explained by another disorder (eg, substance use, posttraumatic stress)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dissociative identity disorder</strong></p></td><td><ul><li>Marked discontinuity in identity &amp; loss of personal agency with fragmentation into &ge;2 distinct personality states</li><li>Associated with severe trauma/abuse</li></ul></td></tr></tbody></table><br />&nbsp;</div><p>This patient&#39;s inability to recall important autobiographical information is suggestive of <strong>dissociative amnesia</strong>.&nbsp; It can consist of localized or selective <strong>amnesia</strong> for a particular event or, as in this patient, more generalized amnesia for <strong>personal identity</strong> and <strong>history</strong>.&nbsp; Onset is typically sudden and preceded by overwhelming or intolerable events.</p><p>If the amnesia is associated with traveling or wandering, the term &#x22;dissociative fugue&#x22; (previously a separate diagnosis in DSM-IV) is used as a specifier for dissociative amnesia in DSM-5.</p><p>Definitive diagnosis requires ruling out effects of a substance (alcohol &#x22;blackouts,&#x22; drugs, medications) or a neurological condition.&nbsp; Dissociative amnesia is not diagnosed if the disturbance is better explained as a symptom of acute or post-traumatic stress disorder (PTSD) or dissociative identity disorder.</p><p><strong>(Choices A and F)</strong>&nbsp; Symptoms of acute stress disorder and PTSD can include dissociative amnesia.&nbsp; However, symptoms of hyperarousal (eg, hypervigilance, startle response, sleep disturbance), intrusive memories, and avoidance behaviors would be expected.</p><p><strong>(Choice B)</strong>&nbsp; Patients with brief psychotic disorder present with delusions, hallucinations, disorganized behavior, or confused speech, none of which this patient displays.&nbsp; This disorder is often precipitated by a stressor and resolves within a month.</p><p><strong>(Choice C)</strong>&nbsp; In depersonalization/derealization disorder, the patient generally has intact autobiographical memory but experiences repeated or chronic feelings of unreality or detachment.</p><p><strong>(Choice E)</strong>&nbsp; Although gaps in memory can be experienced in dissociative identity disorder, the diagnosis requires evidence of 2 or more distinct identities that alternate in assuming control of the patient&#39;s behavior.&nbsp; This patient is acutely confused about his identity and shows no evidence of having developed 2 or more distinct personalities.</p><p><strong>(Choice G)</strong>&nbsp; Transient global amnesia presents as anterograde amnesia for time and place.&nbsp; There is no associated loss of personal identity, as in this patient.&nbsp; The memory loss typically resolves within 24 hours.</p><p><strong>Educational objective:</strong><br>Dissociative amnesia involves isolated impairment in autobiographical memory.&nbsp; If the amnesia is accompanied by travel or wandering, the specifier of &#x22;with dissociative fugue&#x22; is given.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17052,
            "topic": "Dissociative amnesia",
            "titleId": 17052,
            "title": "Dissociative amnesia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 754,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 2,
                    "correctTaken": 324,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depersonalization/derealization disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1465,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dissociative amnesia",
                    "choiceNumber": 4,
                    "correctTaken": 11328,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dissociative identity disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Post-traumatic stress disorder",
                    "choiceNumber": 6,
                    "correctTaken": 40,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transient global amnesia",
                    "choiceNumber": 7,
                    "correctTaken": 1566,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23394228",
                    "mediaDataId": 0,
                    "title": "Dissociative disorders in DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23394228",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 17022,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 8,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 11231,
            "questionIndex": 12384,
            "questionText": "<p>A 24-year-old woman is brought to the emergency department by her roommate due to depression and suicidal thoughts.&nbsp; The roommate became alarmed when the patient did not get up for work as usual and reported feeling &#x22;so depressed I want to die.&#x22;&nbsp; She currently has no suicidal ideation but describes feeling depressed, exhausted, and unable to concentrate.&nbsp; The patient appears distracted and speaks slowly.&nbsp; The roommate says, &#x22;We were up for the last 3 nights at parties where there was alcohol and other stuff,&#x22; but reports that her friend was energetic and talkative and appeared to be in a great mood.&nbsp; However, the patient subsequently slept for 18 hours, had difficulty getting out of bed, and missed work.&nbsp; She has no medical or psychiatric history but describes brief periods of acute depression over the past several months.&nbsp; These lasted a few days and were characterized by low energy; hypersomnia; vivid, unpleasant dreams; and increased appetite.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/70 mm Hg, pulse is 70/min, and respirations are 12/min.&nbsp; Physical examination is normal.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s acute onset of depression with pronounced fatigue following a period of increased energy is suggestive of <strong>cocaine withdrawal</strong>.&nbsp; Individuals often use cocaine in binges, taking the drug repeatedly over a short period to maintain their &#x22;high.&#x22;&nbsp; Abrupt cessation is typically followed by a &#x22;crash,&#x22; which can include severe depression with suicidal ideation and psychomotor slowing with milder symptoms that resolve within 1-2 weeks.&nbsp; Cocaine withdrawal involves predominantly psychological features.&nbsp; Common symptoms include <strong>depression, </strong>fatigue, hypersomnia, <strong>increased dreaming, hyperphagia, </strong>impaired concentration, and intense <strong>drug craving</strong>.&nbsp; Physical symptoms are minor and rarely require treatment.</p><p><strong>(Choices A and F)</strong>&nbsp; This patient&#39;s normal physical examination and vital signs make alcohol and opiate withdrawal syndromes unlikely.&nbsp; Alcohol withdrawal is characterized by CNS hyperactivity, and its symptoms include anxiety, insomnia, tremulousness, tachycardia, and hypertension.&nbsp; Opiate withdrawal typically presents with dysphoria and is accompanied by myalgia, yawning, and abdominal cramping.&nbsp; Physical findings include mydriasis, lacrimation, increased bowel sounds, and piloerection.</p><p><strong>(Choices B, D, and E)</strong>&nbsp; Primary mood disorders should be diagnosed only when substance-induced causes are ruled out, and they are less likely in this patient given her history of using substances at parties.&nbsp; In addition, the patient&#39;s episode of heightened energy does not meet the duration criteria for either a hypomanic (&#8805;4 days) or manic (&#8805;7 days) episode, and her mood symptoms do not meet the duration criteria for either cyclothymia (&#8805;2 years) or major depressive disorder (&#8805;2 weeks).</p><p><strong>Educational objective:</strong><br>Although physical symptoms are typically minor, cocaine withdrawal can cause acute depression with suicidal ideation.&nbsp; Other features include fatigue, hypersomnia, increased dreaming, hyperphagia, impaired concentration, and intense drug craving.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24164,
            "topic": "Substance induced mood disorder",
            "titleId": 24164,
            "title": "Substance induced mood disorder",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 1,
                    "correctTaken": 435,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2566,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cocaine withdrawal",
                    "choiceNumber": 3,
                    "correctTaken": 11312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclothymic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1607,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opiate withdrawal",
                    "choiceNumber": 6,
                    "correctTaken": 249,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "111",
                    "mediaDataId": 0,
                    "title": "Stimulant use disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22856661",
                    "mediaDataId": 0,
                    "title": "Diagnosis and consequences of cocaine addiction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22856661",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 116,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16836,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 666,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 19929,
            "questionIndex": 21418,
            "questionText": "<p>A 5-year-old girl is brought to the office due to behavioral changes.&nbsp; The mother says, &#x22;We took her to a magic show a few months ago and bought a toy wand from the gift shop.&nbsp; Now she thinks she has special powers.&#x22;&nbsp; The patient brings the wand to school each morning so that &#x22;bad things don&#39;t happen.&#x22;&nbsp; A week ago, she forgot to bring her wand home, and that night, her father was in a motor vehicle collision that resulted in a fractured wrist.&nbsp; The patient says, &#x22;Dad got hurt because of me.&nbsp; It was my fault.&#x22;&nbsp; She has become more protective of the wand and no longer shares it with her classmates because &#x22;it will lose its power.&#x22;&nbsp; Each night before falling asleep, the patient closes her eyes and taps her wand in the air 3 times to make sure she and her family stay safe.&nbsp; Vital signs are within normal limits; growth curves are tracking consistently.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This girl&#39;s belief that her magic wand can directly influence events around her is characteristic of <strong>magical thinking</strong>, a normal phase of cognitive development in children age 2-7.&nbsp; During this phase, children often combine <strong>fantasy elements</strong> taken from toys and entertainment with real life events.&nbsp; They can have strong beliefs in the magical powers of objects and the existence of imaginary characters (eg, tooth fairy, fantasy characters, imaginary friends).&nbsp; This girl&#39;s belief that she directly caused her father&#39;s injury by forgetting her wand is also an example of the egocentric thinking that characterizes normal cognitive development during these years; young children often see an event as it relates to themselves only and may feel responsible when something bad happens.</p><p>This girl should be <strong>reassured</strong> that her behavior in no way caused her father&#39;s accident.&nbsp; The parents should be reassured that magical thinking is a <strong>normal developmental stage</strong> that may help children face their fears, resolve conflicts, and develop their imagination and creative thinking.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorders are characterized by emotional or behavioral disturbances that are out of proportion to precipitating stressors and are functionally impairing.&nbsp; This child&#39;s behavior is age appropriate, and there was no obvious precipitant stressor that preceded her belief in the wand&#39;s magic powers.&nbsp; Her reaction to her father&#39;s accident is also consistent with normal cognitive development.</p><p><strong>(Choice C)</strong>&nbsp; Pediatric obsessive-compulsive disorder (OCD) is characterized by time-consuming repetitive compulsions performed in response to obsessional thoughts.&nbsp; This girl&#39;s bedtime ritual is performed only once and is connected to her age-appropriate magical thinking.&nbsp; In addition, onset of pediatric OCD is typically in middle, rather than early, childhood.</p><p><strong>(Choice D)</strong>&nbsp; Although magical thinking can be seen in patients who go on to develop schizotypal personality disorder, it would typically be accompanied by a persistent pattern of unusual perceptual experiences, eccentric behavior, and excessive social anxiety.&nbsp; This child&#39;s magical thinking is developmentally appropriate and likely to be outgrown.</p><p><strong>(Choice E)</strong>&nbsp; Although separation anxiety disorder involves fears of harm to major attachment figures, this patient is attending school without difficulty and does not have excessive distress with separation.</p><p><strong>Educational objective:</strong><br>Young children often engage in magical thinking, involving beliefs in the magical powers of objects and the existence of imaginary characters.&nbsp; It is a normal phase of cognitive development in children age 2-7.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330634,
            "topicAttribute": "Normal behavior and development",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Age-appropriate development",
                    "choiceNumber": 2,
                    "correctTaken": 16061,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 3121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizotypal personality traits",
                    "choiceNumber": 4,
                    "correctTaken": 649,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Separation anxiety disorder",
                    "choiceNumber": 5,
                    "correctTaken": 236,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30725780",
                    "mediaDataId": 0,
                    "title": "Cognitive development.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30725780",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 35,
            "notes": null,
            "peopleTaken": 20697,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1296,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 22071,
            "questionIndex": 105921,
            "questionText": "<p>A 66-year-old man comes to the office to follow up on his prostate cancer treatment.&nbsp; The patient has painful, bony metastasis in the pelvis and is being treated with hormonal therapy and radiotherapy.&nbsp; He has been receiving long-acting and as-needed short-acting morphine, but he continues to have significant pain.&nbsp; In the past 2 weeks, the patient has also experienced insomnia due to the pain, leading to worsening fatigue.&nbsp; He has no nausea, constipation, drowsiness, or suicidal ideation.&nbsp; Urine drug screen is positive for opioids and negative for other substances.&nbsp; A review of the state prescription drug monitoring program database reveals no irregularities.&nbsp; In addition to titration of opioid therapy to improve pain control, which of the following responses is the most appropriate recommendation for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Patients receiving <strong>chronic opioid therapy</strong> are at risk for opioid overdose, including those with cancer.&nbsp; In general, patients with prostate cancer and isolated bony metastasis can live for many years; therefore, balancing adequate pain control versus avoiding opioid overdose is crucial.</p><p>Because overdose leads to fatal respiratory depression, <strong>naloxone</strong>, an opioid receptor antagonist, should be <strong>offered</strong> to <strong>every patient</strong> receiving chronic opioid therapy, especially those at high risk for overdose; <strong>family members</strong> should be trained on its use.&nbsp; Naloxone reverses the effects of opioid toxicity and can be administered intranasally or intramuscularly by bystanders pending arrival of emergency medical services.</p><p>Patients at <strong>high risk for overdose</strong> include those with the following characteristics:</p><ul><li><strong>Escalating</strong> or <strong>high-dose</strong> opioid therapy, such as this patient</li><li>Concurrent <strong>benzodiazepine</strong> use</li><li>History of substance use disorder or overdose</li><li>Close contacts (eg, children) who may accidentally ingest the drug</li></ul><p><strong>(Choice A)</strong>&nbsp; Calcitonin is often used as adjunctive therapy for patients with painful acute osteoporotic vertebral fracture but is generally not used to treat metastatic bone pain due to lack of evidence regarding its efficacy.</p><p><strong>(Choice B)</strong>&nbsp; Concurrent use of a benzodiazepine (eg, clonazepam) with an opioid is highly discouraged due to the increased risk for fatal respiratory depression.&nbsp; Appropriate pain control might help with insomnia.</p><p><strong>(Choice D)</strong>&nbsp; Naltrexone, an opioid antagonist, is used to treat opioid use disorder; it blocks the euphoric effects of opioids and suppresses cravings.&nbsp; Naltrexone is typically initiated after the patient has stopped taking opioids for 1-2 weeks and is not used with an opioid.</p><p><strong>Educational objective:</strong><br>Opioid overdose causes fatal respiratory depression.&nbsp; Naloxone should be offered to every patient who receives chronic opioid therapy, especially those at high risk for overdose (eg, high or escalating opioid dosage, concurrent benzodiazepine use).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14961,
            "topic": "Opioids",
            "titleId": 14961,
            "title": "Opioids",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Bone pain is especially difficult to treat.&nbsp; Let&#39;s try a medication called calcitonin.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 2629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I&#39;ll prescribe you clonazepam every night to help with sleep.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 3056,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I&#39;ll prescribe naloxone in case of overdose and talk to your family about how to use it.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 11802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;To prevent addiction, I&#39;ll prescribe naltrexone to lessen the euphoria associated with morphine.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 2938,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "574,739,true,-1,1*825,1028,true,-1,1*1481,1745,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31864155",
                    "mediaDataId": 0,
                    "title": "Coprescription of opioid and naloxone in office-based practice and emergency department settings in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31864155",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 20425,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1582,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 11034,
            "questionIndex": 12173,
            "questionText": "<p>A 46-year-old hospitalized man is evaluated for confusion.&nbsp; He was admitted 3 days ago after a motor vehicle collision in which he was a passenger.&nbsp; He sustained fractures of the right tibia and fibula, which were surgically reduced and fixed.&nbsp; The patient had a small subdural hematoma without midline shift, which was managed nonoperatively.&nbsp; He has been receiving intravenous morphine for pain control.&nbsp; This morning, the patient was agitated and disruptive and was talking to persons who were not there.&nbsp; He has no significant medical history and takes no regular medications.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 170/100 mm Hg, pulse is 120/min and regular, and respirations are 22/min.&nbsp; Pulse oximetry shows 96% on room air.&nbsp; The patient appears diaphoretic and tremulous and is trying to pull out the intravenous lines.&nbsp; He is not cooperative for funduscopic examination, but pupils are equal and reactive bilaterally.&nbsp; Breath sounds are normal and no heart murmurs are heard.&nbsp; The abdomen is soft and nontender.&nbsp; The surgical incision shows no surrounding erythema.&nbsp; The patient moves all extremities without limitations.&nbsp; Which of the following is the most likely cause of this patient&#39;s acute confusion?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32062\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Alcohol withdrawal syndrome</strong></p></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Manifestations</strong></p></td><td><p align=\"center\"><strong>Symptoms/signs</strong></p></td><td style=\"width: 20%;\"><p align=\"center\"><strong>Onset since last<br />drink (hr)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mild<br />withdrawal</strong></p></td><td><p>Anxiety, insomnia, tremors, diaphoresis, palpitations, gastrointestinal upset, intact orientation</p></td><td><p align=\"center\">6-24</p></td></tr><tr><td><p align=\"center\"><strong>Seizures</strong></p></td><td><p>Single or multiple generalized tonic-clonic</p></td><td><p align=\"center\">12-48</p></td></tr><tr><td><p align=\"center\"><strong>Alcoholic<br />hallucinosis</strong></p></td><td><p>Visual, auditory, or tactile; intact orientation; stable vital signs</p></td><td><p align=\"center\">12-48</p></td></tr><tr><td><p align=\"center\"><strong>Delirium<br />tremens</strong></p></td><td><p>Confusion, agitation, fever, tachycardia, hypertension, diaphoresis, hallucinations</p></td><td><p align=\"center\">48-96</p></td></tr></tbody></table></div><p>In a patient who has been hospitalized for 72 hours, the onset of <strong>acute change</strong> in cognition and attention, tachycardia, hypertension, tremulousness, diaphoresis, <strong>agitation</strong>, and <strong>hallucinations</strong> should raise suspicion for <strong>delirium tremens</strong> (DT) due to alcohol withdrawal.</p><p>Chronic alcohol use results in insensitivity to GABA, the neurotransmitter principally responsible for maintaining inhibitory tone.&nbsp; In contrast, a prolonged decrease in or cessation of alcohol intake leads to disequilibrium between inhibition and excitation, favoring excitation of the central, somatic, and autonomic nervous systems.</p><p>A history of alcohol consumption may go <strong>undetected</strong> in patients who have trauma or encephalopathy.&nbsp; Manifestations of withdrawal may be mistaken for symptoms of the concurrent condition or surgery.&nbsp; These manifestations vary based on quantity, duration, and time since the last drink and may include:</p><ul><li>Early withdrawal (6-36 hours) - tremor, anxiety, headache, normal sensorium</li><li>Neuropsychiatric (12-48 hours) - generalized seizures, hallucinations</li><li>DT (48-96 hours) - altered sensorium, agitation, tremor, <strong>autonomic instability</strong></li></ul><p>Management of DT includes ruling out other causes of delirium, providing nutritional and electrolyte supplementation, and administering benzodiazepines.</p><p><strong>(Choice B)</strong>&nbsp; Elevated intracranial pressure usually manifests with lethargy or obtundation, pupillary abnormalities (eg, enlarged, asymmetric, nonreactive), and Cushing response (eg, hypertension, bradycardia, respiratory depression).&nbsp; Although this patient has a subdural hematoma, he has normal, reactive pupils and is agitated and tachycardic.</p><p><strong>(Choice C)</strong>&nbsp; Fat embolism syndrome occurs 1-3 days following a traumatic injury with the triad of petechiae, pulmonary infiltrates with hypoxia, and altered mentation.&nbsp; This patient has only altered mentation.</p><p><strong>(Choice D)</strong>&nbsp; Malignant hyperthermia is an autosomal dominant disorder of skeletal muscle hypermetabolism that leads to hyperpyrexia, muscle rigidity and breakdown, and respiratory and metabolic acidosis.&nbsp; It occurs rarely and usually only perioperatively with exposure to volatile anesthetics and/or succinylcholine.</p><p><strong>(Choice E)</strong>&nbsp; Neuroleptic malignant syndrome is a reaction to neuroleptic medications (eg, haloperidol, fluphenazine) that results in severe (&#x22;lead pipe&#x22;) muscle rigidity, hyperthermia, delirium, and autonomic instability.&nbsp; This patient is not on neuroleptic medication and does not have a fever.</p><p><strong>(Choice F)</strong>&nbsp; Opiate intoxication leads to lethargy, constricted pupils, and respiratory depression.</p><p><strong>(Choice G)</strong>&nbsp; Pulmonary embolism is a potential postoperative complication usually presenting with chest pain, dyspnea, hypoxia, tachycardia, and diaphoresis.&nbsp; Delirium and agitation would be an uncommon presentation, but this patient is not hypoxemic.</p><p><strong>Educational objective:</strong><br>Delirium tremens is a severe manifestation of alcohol withdrawal usually presenting 48-96 hours after the last drink.&nbsp; It is defined by autonomic excitation, agitation, tremor, and altered sensorium.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 16983,
            "topic": "Alcohol withdrawal",
            "titleId": 16983,
            "title": "Alcohol withdrawal",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Delirium tremens",
                    "choiceNumber": 1,
                    "correctTaken": 16145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated intracranial pressure",
                    "choiceNumber": 2,
                    "correctTaken": 1075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fat embolism syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 1460,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant hyperthermia",
                    "choiceNumber": 4,
                    "correctTaken": 102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroleptic malignant syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opiate intoxication",
                    "choiceNumber": 6,
                    "correctTaken": 449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary embolism",
                    "choiceNumber": 7,
                    "correctTaken": 76,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "767,822,true,-1,1*2215,2294,true,-1,1*2503,2539,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12724485",
                    "mediaDataId": 0,
                    "title": "Management of drug and alcohol withdrawal.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12724485",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 236,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 19607,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1139,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 23242,
            "questionIndex": 107408,
            "questionText": "<p>A 6-year-old girl is brought to the office by her father due to hyperactivity and impulsivity for the past 4 months.&nbsp; The father says, &#x22;She has so much energy at home and seems to calm down only if she&#39;s watching television.&#x22;&nbsp; He read a book on discipline but states it did not help him change the patient&#39;s behaviors.&nbsp; The patient is often impatient, takes her siblings&#39; toys without asking, and runs off at the grocery store.&nbsp; Their house is undergoing a renovation, and despite being told to stay out of the construction zone multiple times, the patient continues to be disobedient.&nbsp; Her school reported no behavioral concerns at a parent-teacher conference 3 weeks ago, and the patient receives average marks on progress reports.&nbsp; Vital signs are normal; growth curves are tracking consistently.&nbsp; Physical examination shows no abnormalities.&nbsp; She plays quietly on her father&#39;s phone during the visit.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T85571\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width: 20%;\"><p align=\"center\"><strong>Parent management training</strong></p></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Focus</strong></p></td><td colspan=\"2\" style=\"width: 80%;\"><p align=\"center\"><strong>Parent interventions</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antecedents</strong></p><p align=\"center\">(communication<br>leading to<br>wanted/unwanted<br>behaviors)</p></td><td style=\"width: 40%;\"><ul><li>Use (promote wanted behavior):<ul style=\"list-style-type:circle;\"><li>clear instructions</li><li>calm tones &amp; supportive gestures</li><li>alternative choices</li></ul></li></ul></td><td style=\"width: 40%;\"><ul><li>Avoid (promote unwanted behavior):<ul style=\"list-style-type:circle;\"><li>nagging</li><li>threats</li><li>harsh comments</li><li>physical intimidation</li></ul></li></ul></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Behaviors</strong></p><p align=\"center\">(practicing effective<br>parent-child<br>interactions)</p></td><td style=\"width: 40%;\"><ul><li>Shaping:<ul style=\"list-style-type:circle;\"><li>small behavioral goals adding to bigger changes</li></ul></li></ul></td><td style=\"width: 40%;\"><ul><li>Role-play wanted behaviors:<ul style=\"list-style-type:circle;\"><li>artificial situations first</li><li>build to realistic scenarios</li></ul></li></ul></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Consequences</strong></p><p align=\"center\">(for wanted/<br>unwanted<br>behaviors)</p></td><td style=\"width: 40%;\"><ul><li>Reinforce wanted behaviors:<ul style=\"list-style-type:circle;\"><li>praise (verbal, nonverbal)</li><li>token/point system rewards</li></ul></li></ul></td><td style=\"width: 40%;\"><ul><li>Manage unwanted behaviors:<ul style=\"list-style-type:circle;\"><li>extinction (eg, ignore, walk away)</li><li>mild punishment (eg, privilege loss)</li></ul></li></ul></td></tr></tbody></table></div><p><strong>Hyperactivity and impulsivity</strong> (eg, being overly energetic, running off, taking toys) are nonspecific features that may be due to attention deficit hyperactivity disorder [ADHD]) or another cause (eg, ineffective parenting, personality traits).&nbsp; When symptoms are frequent, cause impairment, and present across multiple settings (eg, school, home, physician&#39;s office), ADHD&mdash;for which effective medication management exists (eg, norepinephrine reuptake inhibitors [eg, atomoxetine], stimulants [eg, methylphenidate], alpha-2 adrenergic agonists [eg, clonidine])&mdash;should be considered <strong>(Choices B and F)</strong>.</p><p>However, when parents describe a child&#39;s <strong>disobedience</strong> as <strong>limited to the home setting</strong>, problems specific to the <strong>parent-child relationship</strong> should be suspected.&nbsp; In this situation, where the father has tried unsuccessfully to manage by using a self-help book, <strong>parent management training</strong> (PMT) is the treatment of choice and provides an effective intervention for his daughter&#39;s inappropriate behaviors <strong>(Choice D)</strong>.</p><p>PMT helps parents identify effective parenting methods while redirecting them from ineffective methods.&nbsp; Sessions usually last 5-10 weeks and seek to <strong>identify antecedents</strong> (ie, causes) of a child&#39;s behaviors and provide a forum for <strong>practicing effective behavioral interventions</strong>.&nbsp; Parents are also taught how to provide <strong>consistent consequences</strong> that promote wanted behaviors (eg, targeted praise, point systems) and decrease unwanted behaviors through extinction (eg, ignoring, walking away) and mild punishment (eg, privilege loss).</p><p><strong>(Choice A)</strong>&nbsp; Modifying the patient&#39;s screen time should be a part of the overall management strategy because using it to help her &#x22;calm down&#x22; is rewarding, which reinforces the unwanted behaviors; however, the disobedience is not limited to screen time (eg, runs off at the grocery store, takes siblings&#39; toys), so this alone is not expected to bring the long-term changes needed.</p><p><strong>(Choice C)</strong>&nbsp; Lead poisoning can cause behavior and cognitive concerns in children; however, these would be expected to cross multiple settings.&nbsp; Parent-specific disobedience and average grades suggest ineffective parenting techniques.</p><p><strong>Educational objective:</strong><br>When hyperactivity and impulsivity concerns are limited to the home setting, ineffective parenting methods should be suspected, with parent management training being the treatment of choice.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Advise the father to discontinue screen time",
                    "choiceNumber": 1,
                    "correctTaken": 915,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin a methylphenidate trial",
                    "choiceNumber": 2,
                    "correctTaken": 674,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a blood lead level",
                    "choiceNumber": 3,
                    "correctTaken": 978,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance that the patient&#39;s behaviors are age appropriate",
                    "choiceNumber": 4,
                    "correctTaken": 6802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend parent management training",
                    "choiceNumber": 5,
                    "correctTaken": 7473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start clonidine",
                    "choiceNumber": 6,
                    "correctTaken": 55,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 167,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16897,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 726,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 13675,
            "questionIndex": 15065,
            "questionText": "<p>A 45-year-old woman comes to the office for evaluation of &#x22;muscle tightness.&#x22;&nbsp; The patient reports having stiffness and muscle pain in her neck and shoulders for the past few months.&nbsp; She was previously a stay-at-home mom but started a new job as a receptionist 6 months ago and spends most of her time seated at a desk.&nbsp; The patient notes feeling increasingly stressed and fatigued since she started working and cannot get through the day without feeling overwhelmed.&nbsp; The patient finds herself thinking about &#x22;anything but work,&#x22; including whether her son will get into college and if her husband will get a raise.&nbsp; She often texts her kids to check-in with them throughout the day and calls at 4 PM to make sure they arrived home safely.&nbsp; When she gets home in the evenings, she prefers to spend time alone because she tends to get easily irritated by her family.&nbsp; Medical history is noncontributory.&nbsp; The patient takes no medications.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69535\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Excessive, uncontrollable worry (multiple issues) &ge;6 months</li><li>&ge;3 of the following symptoms (&ge;1 in children):<ul><li>Restlessness, feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li></ul><ul><li>Chronic, fluctuating course; academic/occupational dysfunction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated features</strong></p></td><td><ul><li>Physical symptoms related to tension (headaches, neck pain)</li><li>Comorbid depression, substance use common</li><li>Increased risk of high health care utilization, cardiovascular events</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Cognitive-behavioral therapy</li><li>SSRI or SNRI</li><li>Buspirone</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>&#8805;6-month</strong> history of feeling overwhelmed by <strong>anxious thoughts</strong> (eg, health, family, safety, finances), accompanied by symptoms of <strong>muscle tension, irritability, impaired concentration</strong>, and <strong>fatigue</strong>, is consistent with <strong>generalized anxiety disorder</strong> (GAD).&nbsp; Patients with GAD experience chronic and pervasive anxiety and worry excessively about everyday matters.&nbsp; They often describe lifelong anxiety but frequently experience worsening symptoms during periods of increased stress, such as this patient&#39;s starting a new job.&nbsp; Symptoms of GAD may also include feeling <strong>restless/on edge</strong> and <strong>sleep disturbance</strong> characterized by difficulty falling and staying asleep.</p><p>Patients with GAD frequently seek medical attention in the primary care setting for physical symptoms related to muscle tension or for concerns about fatigue or poor sleep.&nbsp; This patient&#39;s neck and shoulder pain is a common presentation.</p><p><strong>(Choice A)</strong>&nbsp; In adjustment disorder, emotional and behavioral symptoms develop within 3 months in response to an identifiable stressor and do not meet the criteria for any other mental disorder.&nbsp; This patient&#39;s anxiety has persisted &#8805;6 months and is consistent with GAD due to her excessive worry about multiple topics and associated physical symptoms.</p><p><strong>(Choice C)</strong>&nbsp; There is significant symptom overlap between major depressive disorder and GAD (eg, fatigue, insomnia, impaired concentration).&nbsp; However, this patient&#39;s lack of key depressive symptoms (ie, sadness, decreased interest, anhedonia) and prominent, overwhelming anxiety make GAD the more accurate diagnosis.</p><p><strong>(Choice D)</strong>&nbsp; Although this patient is preoccupied with anxious thoughts, she lacks the intrusive, unwanted obsessions and repetitive, ritualistic, compulsive acts required for diagnosis of obsessive-compulsive disorder (OCD).&nbsp; Patients with GAD tend to seek reassurance directly (eg, calling home to check on children), whereas compulsive behaviors in OCD are often unrealistically connected to preventing a feared outcome (eg, repeatedly counting to a certain number to prevent illness in a child).</p><p><strong>(Choice E)</strong>&nbsp; Anxiety about physical symptoms occurs in both GAD and somatic symptom disorder (SSD).&nbsp; However, in contrast to SSD, patients with GAD typically have multiple worries about everyday concerns and are not exclusively focused on medically unexplained symptoms.</p><p><strong>Educational objective:</strong><br>Generalized anxiety disorder is characterized by overwhelming and pervasive anxiety lasting &#8805;6 months.&nbsp; Associated symptoms include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1849,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 2,
                    "correctTaken": 10197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 5,
                    "correctTaken": 668,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "293,355,true,-1,1*260,274,true,-1,1*478,547,true,-1,1*600,609,true,-1,1*1378,1549,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30934083",
                    "mediaDataId": 0,
                    "title": "Generalized anxiety disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30934083",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 156,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 13072,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 668,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 3536,
            "questionIndex": 3536,
            "questionText": "<p>A 60-year-old physician is admitted to the hospital for jaundice and weight loss.&nbsp; His medical history is noncontributory.&nbsp; After a detailed workup, advanced pancreatic carcinoma is diagnosed.&nbsp; Although the patient is advised to slow down and spend more time with his family, he insists on continuing to work, saying, &#x22;It&#39;s a good distraction to think about other people&#39;s medical problems.&#x22;&nbsp; Each day after work, he spends several hours reviewing and analyzing his own diagnostic tests and researching experimental chemotherapy regimens for pancreatic cancer.&nbsp; The patient&#39;s family members wish he would take time off to rest, but he insists that would make him feel worse.&nbsp; Which of the following psychological defense mechanisms is the best explanation for this patient&#39;s behavior?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40956\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Key defense mechanisms</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Immature </strong></p></td><td><ul><li>Acting out: Expressing unacceptable feelings through actions</li><li>Denial: Behaving as if an aspect of reality does not exist</li><li>Displacement: Transferring feelings to less threatening object/person</li><li>Intellectualization: Focusing on nonemotional aspects to avoid distressing feelings</li><li>Passive aggression: Avoiding conflict by expressing hostility covertly</li><li>Projection: Attributing one&rsquo;s own feelings to others</li><li>Rationalization: Justifying behavior to avoid difficult truths</li><li>Reaction formation: Transforming unacceptable feelings/impulses into the opposite</li><li>Regression: Reverting to earlier developmental stage</li><li>Splitting: Experiencing a person/situation as either all positive or all negative</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Mature</strong></p></td><td><ul><li>Sublimation: Channeling impulses into socially acceptable behaviors</li><li>Suppression: Putting unwanted feelings aside to cope with reality</li></ul></td></tr></tbody></table></div><p><strong>Psychological defense mechanisms</strong> are <strong>unconscious</strong> means of responding and adapting to emotional stressors that serve to decrease anxiety and provide a sense of security or control.&nbsp; This patient is primarily employing <strong>intellectualization</strong>, a defense mechanism that allows him to <strong>avoid anxiety</strong> by <strong>focusing</strong> on the <strong>nonemotional aspects</strong> of his cancer diagnosis.</p><p>His decision to keep working serves as an intellectual focus as he spends hours a day analyzing test results and researching experimental therapies <strong>rather than confronting the painful emotions</strong> associated with his poor prognosis.&nbsp; His overreliance on intellectualization interferes with his ability to deal with his feelings and grieve with his family.</p><p><strong>(Choice A)</strong>&nbsp; Altruism involves managing unpleasant emotions through unselfish devotion or service to others.&nbsp; This patient&#39;s decision to keep working is primarily motivated by his need for an intellectual distraction from his own problems rather than a desire to help others.</p><p><strong>(Choice B)</strong>&nbsp; Denial is the failure to accept a disturbing aspect of external reality (eg, if this patient refused to acknowledge his diagnosis and insisted that nothing was wrong in the face of all evidence to the contrary).</p><p><strong>(Choice C)</strong>&nbsp; Displacement is the transfer of feelings or impulses toward a safer, more acceptable person or situation (eg, if this physician displaced his anxiety by becoming excessively worried about his patients instead of his own condition).</p><p><strong>(Choice E)</strong>&nbsp; Rationalization involves attempting to justify or excuse a behavior or decision rather than acknowledging the true motives, significance, or consequences of it.&nbsp; For example, this would occur if the physician rationalized his decision to keep working by saying he was unable to transfer his patients to another caregiver when this was not the case.</p><p><strong>(Choice F)</strong>&nbsp; Reaction formation involves transforming an unacceptable feeling or impulse into its extreme opposite (eg, if this patient feared dying but behaved in an overly optimistic and fearless manner about his treatment and prognosis).</p><p><strong>Educational objective:</strong><br>Intellectualization is the transformation of a distressing event into a situation devoid of emotion to avoid confrontation of uncomfortable emotional components.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25358,
            "topic": "Defense mechanisms",
            "titleId": 25358,
            "title": "Defense mechanisms",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Altruism",
                    "choiceNumber": 1,
                    "correctTaken": 502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Denial",
                    "choiceNumber": 2,
                    "correctTaken": 1259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Displacement",
                    "choiceNumber": 3,
                    "correctTaken": 944,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intellectualization",
                    "choiceNumber": 4,
                    "correctTaken": 12963,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rationalization",
                    "choiceNumber": 5,
                    "correctTaken": 627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reaction formation",
                    "choiceNumber": 6,
                    "correctTaken": 478,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2101,2332,true,-1,1*2704,2933,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26583439",
                    "mediaDataId": 0,
                    "title": "Understanding defense mechanisms.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26583439",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 39,
            "notes": null,
            "peopleTaken": 16773,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 889,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 2653,
            "questionIndex": 2653,
            "questionText": "<p>A 26-year-old woman is brought to the emergency department by coworkers due to agitated behavior.&nbsp; She is alert but appears distracted by unseen stimuli.&nbsp; During triage, the patient yells at a nurse for being &#x22;too close&#x22; to her; she also attempts to lift an equipment cart and throws the blood pressure cuff across the room.&nbsp; The patient provides nonsensical responses when asked about her medical history.&nbsp; Her coworkers say that she has depression and anxiety but do not know what medications she takes.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 160/90 mm Hg, pulse is 126/min, and respirations are 18/min.&nbsp; Physical examination shows equal and reactive pupils, intact extraocular movements, and nystagmus.&nbsp; Mild rigidity is noted and is most prominent in the upper extremities.&nbsp; Upper and lower limb deep tendon reflexes are 2+.&nbsp; No tremors are observed, and gait is ataxic.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has signs and symptoms of <strong>phencyclidine (PCP) intoxication</strong>, including:</p><ul><li>Disorientation with <strong>severe agitation</strong></li><li><strong>Aggression</strong> with delusions of enhanced strength</li><li><strong>Psychosis</strong> (eg, paranoia, hallucinations)</li><li><strong>Tachycardia</strong>, <strong>hypertension</strong>, hyperthermia</li><li>Nystagmus and ataxia</li></ul><p>PCP is a dissociative drug of abuse that has anesthetic and analgesic properties.&nbsp; It acts on NMDA receptors (excitatory and psychotic effects), dopamine, norepinephrine, and serotonin receptors (adrenergic and dopaminergic effects), and the sigma receptor complex (psychotic and anticholinergic effects).&nbsp; In many cases, PCP use can lead to psychotic and violent behavior, diminished pain perception, and subsequent physical injuries.</p><p>The onset of action is rapid, and the duration of action is generally &lt;8 hours.&nbsp; High doses can cause severe hypertension, seizures, rigidity, and life-threatening hyperthermia.&nbsp; PCP intoxication is treated with both supportive therapy and benzodiazepines.</p><p><strong>(Choice A)</strong>&nbsp; Severe alcohol withdrawal (ie, delirium tremens) can present with confusion and hallucinations, agitation, and hemodynamic instability (eg, tachycardia, hypertension, hyperthermia).&nbsp; Nystagmus can be present in cases with associated cerebellar degeneration.&nbsp; However, alcohol withdrawal typically follows stepwise worsening of symptoms from mild withdrawal, seizures, alcoholic hallucinosis, and then to delirium tremens.&nbsp; In addition, tremors (absent in this patient) are a hallmark of alcohol withdrawal.</p><p><strong>(Choice B)</strong>&nbsp; Cerebellar stroke can present with nystagmus and ataxia but does not cause agitation, aggression, or psychosis.</p><p><strong>(Choice C)</strong>&nbsp; Methamphetamine intoxication can also cause severe psychomotor agitation, hallucinations, tachycardia, and hypertension, but nystagmus is less common.&nbsp; Methamphetamine intoxication may last up to 20 hours (longer than PCP intoxication).</p><p><strong>(Choice D)</strong>&nbsp; Multiple sclerosis can present with nystagmus and ataxia and sometimes behavior changes (eg, inappropriate laughing), but it does not cause severe aggression or hemodynamic changes.</p><p><strong>(Choice F)</strong>&nbsp; Serotonin syndrome is characterized by mental status changes, autonomic dysregulation, and neuromuscular hyperactivity, features seen in this patient.&nbsp; However, the aggression with delusions of enhanced strength, nystagmus, and ataxia are more consistent with PCP intoxication.</p><p><strong>Educational objective:</strong><br>Phencyclidine is a dissociative anesthetic that characteristically causes nystagmus.&nbsp; It can also cause dissociative feelings, psychotic and violent behavior, severe hypertension, and hyperthermia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 20681,
            "topic": "Phencyclidine",
            "titleId": 20681,
            "title": "Phencyclidine",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 1,
                    "correctTaken": 515,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerebellar stroke",
                    "choiceNumber": 2,
                    "correctTaken": 61,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methamphetamine intoxication",
                    "choiceNumber": 3,
                    "correctTaken": 764,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple sclerosis",
                    "choiceNumber": 4,
                    "correctTaken": 30,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phencyclidine intoxication",
                    "choiceNumber": 5,
                    "correctTaken": 8608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 1144,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "674,814,true,-1,1*914,992,true,-1,1*382,604,true,-1,1*1799,1884,true,-1,1*1188,1262,true,-1,1*1441,1511,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25502414",
                    "mediaDataId": 0,
                    "title": "Phencyclidine intoxication case series study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25502414",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 184,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 11122,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 662,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 3806,
            "questionIndex": 3806,
            "questionText": "<p>During bedside rounds, a senior resident is reprimanded by the chief of service for mismanaging the care of a private patient.&nbsp; Although the resident, believing that she made the right decision, is angry about the attending&#39;s assessment, she says nothing.&nbsp; Later that day, she is teaching a group of medical students and asks one of them to list the differential diagnosis of hematuria.&nbsp; After a student lists several diagnostic possibilities but neglects to mention nephrolithiasis, the resident walks out of the room, saying, &#x22;Why do I bother to assign readings if none of you take them seriously?&#x22;&nbsp; The student is upset by this comment and speaks to the resident later in the day, saying, &#x22;I am open to feedback on my performance but would hope that you would not belittle me in public.&#x22;&nbsp; Which of the following defense mechanisms is exhibited by the resident&#39;s behavior toward the student?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40956\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Key defense mechanisms</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Immature</strong></p></td><td><ul><li>Acting out: expressing unacceptable feelings through actions</li><li>Denial: behaving as if an aspect of reality does not exist</li><li>Displacement: transferring feelings to less threatening object/person</li><li>Intellectualization: focusing on nonemotional aspects to avoid distressing feelings</li><li>Passive aggression: avoiding conflict by expressing hostility covertly</li><li>Projection: attributing one&#39;s own feelings to others</li><li>Rationalization: justifying behavior to avoid difficult truths</li><li>Reaction formation: transforming unacceptable feelings/impulses into the opposite</li><li>Regression: reverting to earlier developmental stage</li><li>Splitting: experiencing a person/situation as either all positive or all negative</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Mature</strong></p></td><td><ul><li>Sublimation: channeling impulses into socially acceptable behaviors</li><li>Suppression: putting unwanted feelings aside to cope with reality</li></ul></td></tr></tbody></table></div><p>Psychological <strong>defense mechanisms</strong> are unconscious means of responding and adapting to different situations while preserving self-image.&nbsp; These mechanisms serve to decrease anxiety associated with shame and vulnerability and ensure a feeling of safety in the face of disappointments.&nbsp; Immature defense mechanisms are commonly seen in children or in adults during <strong>times of stress</strong>.&nbsp; They provide short-term relief but often result in long-term complications, such as interpersonal difficulties and misunderstandings.&nbsp; Mature defense mechanisms represent a more constructive way to approach reality.</p><p><strong>Displacement</strong> is an immature defense mechanism that involves <strong>transferring emotions</strong> associated with an upsetting object or person <strong>to a safer, alternate</strong> object or person.&nbsp; This resident likely was shamed and angered by being reprimanded by the chief of service.&nbsp; Instead of acknowledging her feelings, she displaces her anger onto a safer target by making shaming comments to the students she is teaching.</p><p><strong>(Choice A)</strong>&nbsp; Acting out involves expressing unacceptable feelings through impulsive physical actions (eg, if the resident pounded the desk or destroyed items in the attending&#39;s office in response to being criticized).</p><p><strong>(Choice C)</strong>&nbsp; In passive aggression, emotions are expressed in a roundabout way instead of directly (eg, if the resident &#x22;forgot&#x22; about rounds the next day, leaving the attending to manage patients alone).</p><p><strong>(Choice D)</strong>&nbsp; Projection involves attributing one&#39;s own unacceptable feelings to someone else (eg, if the resident, unconsciously harboring anger toward the attending, instead accuses the student of behaving angrily).</p><p><strong>(Choice E)</strong>&nbsp; In regression, people revert to an earlier pattern of behavior or coping, as if they were much younger (eg, if the resident had a temper tantrum in front of the chief of service when he berated her).</p><p><strong>(Choice F)</strong>&nbsp; In splitting, people experience a situation as either all positive or all negative (eg, if the resident alternately idealized and then devalued the chief of service, first believing him to be &#x22;the best attending in the world&#x22; and then &#x22;the worst&#x22;).</p><p><strong>Educational objective:</strong><br>Displacement is an immature defense mechanism in which an individual displaces negative feelings associated with a person or situation onto a safer object or situation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25358,
            "topic": "Defense mechanisms",
            "titleId": 25358,
            "title": "Defense mechanisms",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acting out",
                    "choiceNumber": 1,
                    "correctTaken": 170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Displacement",
                    "choiceNumber": 2,
                    "correctTaken": 11091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Passive aggression",
                    "choiceNumber": 3,
                    "correctTaken": 2342,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Projection",
                    "choiceNumber": 4,
                    "correctTaken": 620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Regression",
                    "choiceNumber": 5,
                    "correctTaken": 70,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splitting",
                    "choiceNumber": 6,
                    "correctTaken": 120,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34721167",
                    "mediaDataId": 0,
                    "title": "The hierarchy of defense mechanisms: assessing defensive functioning with the defense mechanisms rating scales Q-sort.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34721167",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23834293",
                    "mediaDataId": 0,
                    "title": "Change in coping and defense mechanisms across adulthood: longitudinal findings in a European American sample.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23834293",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 36,
            "notes": null,
            "peopleTaken": 14413,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 706,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 14345,
            "questionIndex": 15753,
            "questionText": "<p>An 8-year-old boy is brought to the office by his mother due to difficulties at school.&nbsp; The patient was adopted at age 2 from an orphanage.&nbsp; Medical history is significant for a heart murmur that resolved when he was an infant.&nbsp; His mother says, &#x22;His handwriting is illegible and the school wants to keep him back a grade.&nbsp; He has always struggled to sit still and focus; he is clumsy and breaks things without meaning to.&nbsp; He gets upset easily and throws things or hits his brothers when they don&#39;t do what he wants.&#x22;&nbsp; The patient&#39;s teacher has reported that he doesn&#39;t listen, talks back, and distracts other children.&nbsp; Psychoeducational testing revealed an IQ score of 85.&nbsp; In the office, the boy is playing with a toy.&nbsp; When his mother takes it away, he hits her, starts crying, and becomes difficult to console.&nbsp; Vital signs are within normal limits.&nbsp; Weight and height are tracking at the 30th percentile, but head circumference is below the 10th percentile.&nbsp; Physical examination shows a thin upper lip and short palpebral fissures.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"757\" src=\"https://www.uworld.com/media/L14000.jpg\" ></p><p>This patient&#39;s behavioral difficulties (distractibility, emotional reactivity), growth retardation, and facial anomalies are suggestive of <a href=\"20679\"><strong>fetal alcohol syndrome</strong></a>&nbsp;<strong>(FAS)</strong>.&nbsp; Features of FAS include <strong>facial dysmorphism</strong> (short palpebral fissures, thin upper lip, smooth philtrum), <strong>growth retardation</strong>, and <strong>CNS involvement</strong>, which manifests in structural and/or neurobehavioral difficulties.&nbsp; Other systems that may be affected include the heart, skeletal, renal, ocular, and auditory systems.</p><p>Intrauterine alcohol exposure negatively impacts the fetal brain via inhibition of NMDA and hyperactivation of GABA receptors.&nbsp; Deficits in development of the corpus callosum, cerebellum, and basal ganglia result in abnormal reflexes, tone, and coordination, manifesting in this patient as difficulty with writing and clumsiness.&nbsp; A decrease in the volume of the frontal lobe and dysfunction of the amygdala result in deficits in executive functioning, impulse control, and emotion regulation.&nbsp; Features of attention-deficit hyperactivity disorder (ADHD) are common <strong>(Choice A)</strong>.&nbsp; Other neurobehavioral manifestations include cognitive impairment, seizures, learning disabilities, and social skill deficits.</p><p><strong>(Choices B and H)</strong>&nbsp; DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS) are associated with a deletion of chromosome 22q11 affecting pharyngeal pouch development.&nbsp; DGS presents with abnormal conotruncal cardiac development, a hypoplastic thymus, and hypocalcemia.&nbsp; It is associated with developmental delay and social and emotional skill deficits.&nbsp; VCFS presents with an elongated face, retrognathia, a prominent nose, hypernasal speech, and cardiac defects.&nbsp; Learning disabilities, schizophrenia, and paranoia may be present.</p><p><strong>(Choice C)</strong>&nbsp; Down syndrome (trisomy 21) is associated with epicanthal folds, upslanting palpebral fissures, flat nasal bridge, protruding tongue, and varying degrees of intellectual disability.</p><p><strong>(Choice E)</strong>&nbsp; Fragile X syndrome is the most common form of inherited intellectual disability.&nbsp; It is associated with unstable CGG (cytosine-guanine-guanine) trinucleotide repeats on the X chromosome.&nbsp; Features include intellectual disability; a long, narrow face; large, protruding ears; macrocephaly; and macroorchidism.&nbsp; ADHD and autistic features are common.</p><p><strong>(Choices F and G)</strong>&nbsp; Oppositional defiant disorder is characterized by a pattern of defiant behavior, vindictiveness, and an angry or irritable mood.&nbsp; Reactive attachment disorder presents with lack of positive affect, social and emotional withdrawal, and poor response to comfort.&nbsp; Neither of these conditions would explain facial anomalies or incoordination.</p><p><strong>Educational objective:</strong><br>Neurobehavioral manifestations of fetal alcohol syndrome include intellectual disability, emotional dysregulation, inattention, and social skill deficits.&nbsp; Accompanying features include facial dysmorphism (short palpebral fissures, thin upper lip, smooth philtrum) and growth retardation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 12049,
            "topic": "Fetal alcohol syndrome",
            "titleId": 12049,
            "title": "Fetal alcohol syndrome",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Attention-deficit hyperactivity disorder",
                    "choiceNumber": 1,
                    "correctTaken": 157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "DiGeorge syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 153,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Down syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 1032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal alcohol syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 14364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fragile X syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 6,
                    "correctTaken": 97,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive attachment disorder",
                    "choiceNumber": 7,
                    "correctTaken": 32,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Velocardiofacial syndrome",
                    "choiceNumber": 8,
                    "correctTaken": 221,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "516,1008,true,-1,1*1578,1687,true,-1,1*1420,1452,true,-1,1*414,514,true,-1,1*2074,2127,true,-1,1*2272,2310,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29094891",
                    "mediaDataId": 0,
                    "title": "Fetal alcohol syndrome and fetal alcohol spectrum disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29094891",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28460370",
                    "mediaDataId": 0,
                    "title": "Comorbid mental disorders in fetal alcohol spectrum disorders: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28460370",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25307589",
                    "mediaDataId": 0,
                    "title": "Neurobehavioral, neurologic, and neuroimaging characteristics of fetal alcohol spectrum disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25307589",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 16422,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 775,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 3191,
            "questionIndex": 3191,
            "questionText": "<p>A 37-year-old man is brought to the emergency department by police officers after being found naked and yelling in the street.&nbsp; The patient was walking up to cars stopped at a traffic signal, cursing at drivers, and banging on windows.&nbsp; He has been admitted to the hospital several times due to agitation resulting from substance use.&nbsp; Medical history includes depression.&nbsp; The patient is highly agitated; attempts to elicit a history are unsuccessful.&nbsp; He repeatedly says, &#x22;They are all out to get me.&nbsp; They are coming through the walls, ready to kill me.&#x22;&nbsp; The patient alternates between screaming and pounding on the walls.&nbsp; Temperature is 38.3 C (100.9 F), blood pressure is 148/100 mm Hg, pulse is 98/min, and respirations are 16/min.&nbsp; Physical examination shows ataxia, nystagmus, and muscle rigidity.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T97498\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Management of substance-induced emergencies</strong></p></td></tr><tr><td><p align=\"center\"><strong>Class</strong></p></td><td><p align=\"center\"><strong>Acute clinical features</strong></p></td><td><p align=\"center\"><strong>Management</strong></p></td></tr><tr><td><p align=\"center\"><strong>PCP<br>(phencyclidine)</strong></p></td><td><ul><li>Violent behavior</li><li>Dissociation</li><li>Hallucinations</li><li>Amnesia</li><li><strong>Nystagmus</strong> (horizontal or vertical)</li><li>Ataxia</li></ul></td><td><ul><li>Benzodiazepines</li><li>Antipsychotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cocaine</strong></p></td><td><ul><li>Euphoria</li><li>Agitation/psychosis</li><li><strong>Chest pain</strong></li><li><strong>Seizures</strong></li><li>Tachycardia/hypertension</li><li><strong>Mydriasis</strong></li></ul></td><td><ul><li>Benzodiazepines</li><li>Antipsychotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Methamphetamine</strong></p></td><td><ul><li>Violent behavior</li><li><strong>Psychosis/diaphoresis</strong></li><li>Tachycardia/hypertension</li><li>Choreiform movements</li><li><strong>Tooth decay</strong></li></ul></td><td><ul><li>Benzodiazepines</li><li>Antipsychotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Alcohol</strong></p></td><td><ul><li>Aggression</li><li><strong>Confusion/disorientation</strong></li><li>Depressed mental status</li><li>Respiratory depression</li></ul></td><td><ul><li>Antipsychotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Opioids</strong></p></td><td><ul><li>Euphoria</li><li><strong>Depressed mental status</strong></li><li><strong>Miosis</strong></li><li><strong>Respiratory depression</strong></li><li>Constipation</li></ul></td><td><ul><li>Naloxone</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation suggests <strong>phencyclidine (PCP) intoxication</strong>.&nbsp; PCP acts on the following:</p><ul><li><p>NMDA receptors, particularly in the hippocampus and limbic system (causing excitatory and psychotic effects)</p></li><li><p>Dopamine, norepinephrine, and serotonin receptors (causing adrenergic and dopaminergic effects)</p></li><li><p>The sigma receptor complex (causing psychotic and anticholinergic effects)</p></li></ul><p>Therefore, PCP intoxication commonly presents with severe <strong>agitation, delusions</strong> of enhanced strength, psychosis (eg, paranoia, <strong>hallucinations</strong>), analgesia, and aggression.&nbsp; Physical examination findings include <strong>multidirectional nystagmus</strong> (horizontal, vertical, and/or rotary), hypertension, tachycardia, and <strong>disorientation</strong>.&nbsp; Severe cases may present with hyperthermia, ataxia, muscle rigidity, seizures, and coma.</p><p>The treatment of PCP intoxication involves supportive management and control of agitation and aggression to maintain safety.&nbsp; <strong>Benzodiazepines</strong> (eg, lorazepam, midazolam) are the preferred agents for managing PCP-associated agitation; <strong>lorazepam</strong> has a rapid onset of action, which allows for faster management of behavioral crises.&nbsp; In addition, the sedation achieved with benzodiazepines can help manage complications (eg, hyperthermia, hypertension) and protect against seizures.&nbsp; If there is an incomplete response to benzodiazepines, antipsychotics can be used as adjunctive treatment.</p><p><strong>(Choice A)</strong>&nbsp; Cyproheptadine is a serotonin antagonist that can be used in the management of serotonin syndrome.&nbsp; Muscular rigidity, delirium, hyperthermia, and abnormal eye movements are signs of serotonin syndrome; however, this patient&#39;s history of repeated hospitalizations due to substance use and significant aggression (ie, screaming, pounding on walls) make PCP intoxication more likely.</p><p><strong>(Choice B)</strong>&nbsp; Dexmedetomidine is an agonist at the alpha-2 receptor that is commonly used in the intensive care unit and for procedural sedation.&nbsp; It is not typically used in the treatment of PCP intoxication.</p><p><strong>(Choice D)</strong>&nbsp; Phentolamine is an alpha-adrenergic antagonist that may be used in specific cases of hypertensive emergencies (eg, pheochromocytoma).</p><p><strong>(Choice E)</strong>&nbsp; Urinary acidification, which increases PCP clearance, is no longer recommended as a treatment for PCP intoxication because it is largely ineffective&mdash;it increases clearance by only 1%&mdash;and increases the risk for acidosis and renal damage.</p><p><strong>Educational objective:</strong><br>Phencyclidine intoxication presents with severe agitation, delusions of enhanced strength, psychosis, analgesia, multidirectional nystagmus, hypertension, tachycardia, and disorientation.&nbsp; Agitation and aggression can be managed with benzodiazepines (eg, lorazepam).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 20681,
            "topic": "Phencyclidine",
            "titleId": 20681,
            "title": "Phencyclidine",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cyproheptadine",
                    "choiceNumber": 1,
                    "correctTaken": 564,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dexmedetomidine",
                    "choiceNumber": 2,
                    "correctTaken": 348,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 3,
                    "correctTaken": 12058,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phentolamine",
                    "choiceNumber": 4,
                    "correctTaken": 442,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary acidification",
                    "choiceNumber": 5,
                    "correctTaken": 435,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "3241,3267,true,-1,1*2513,2645,true,-1,1*3017,3104,true,-1,1*827,1108,true,-1,1*1431,1520,true,-1,1*1998,2107,true,-1,1*400,416,true,-1,1*464,484,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25502414",
                    "mediaDataId": 0,
                    "title": "Phencyclidine intoxication case series study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25502414",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 178,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 13847,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 676,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 4215,
            "questionIndex": 4215,
            "questionText": "<p>A 16-year-old boy is brought to the emergency department by his friends for severe anxiety.&nbsp; He became paranoid and unusually withdrawn at a party and began rocking back and forth, saying, &#x22;I feel like I can&#39;t breathe&#x22; and &#x22;I&#39;m afraid I&#39;m going to die.&#x22;&nbsp; Prior to the party, he was his regular &#x22;happy and outgoing&#x22; self.&nbsp; The patient has intermittent back pain from a bicycle accident last year for which he takes oxycodone as needed.&nbsp; Temperature is 36.1 C (97 F), blood pressure is 140/80 mm Hg, pulse is 110/min, and respirations are 18/min.&nbsp; Pulse oximetry is 98% on room air.&nbsp; Examination shows an anxious and withdrawn boy with 3-mm pupils, conjunctival injection, dry oral mucosa, and a healed scar on his right thigh from his bicycle accident.&nbsp; Which of the following is most consistent with this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33448\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100.0%\"><tbody><tr><td colspan=\"3\" style=\"width:100.0%\"><p align=\"center\"><strong>Acute drug intoxication</strong></p></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>Drug</strong></p></td><td style=\"width:20.84%\"><p align=\"center\"><strong>Class</strong></p></td><td style=\"width:49.74%\"><p style=\"margin-left:.25in;\"><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Clinical features</strong></p></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>PCP</strong></p></td><td style=\"width:20.84%\"><p align=\"center\">Hallucinogen</p></td><td style=\"width:49.74%\"><ul><li>Violent behavior</li><li>Dissociation</li><li>Hallucinations</li><li>Amnesia</li><li><strong>Nystagmus</strong> (horizontal or vertical)</li><li>Ataxia</li></ul></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>LSD</strong></p></td><td style=\"width:20.84%\"><p align=\"center\">Hallucinogen</p></td><td style=\"width:49.74%\"><ul><li><strong>Visual hallucinations</strong></li><li>Euphoria</li><li>Dysphoria/panic</li><li>Tachycardia/hypertension</li></ul></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>Cocaine</strong></p></td><td style=\"width:20.84%\"><p align=\"center\">Stimulant</p></td><td style=\"width:49.74%\"><ul><li>Euphoria</li><li>Agitation/psychosis</li><li><strong>Chest pain</strong></li><li><strong>Seizures</strong></li><li>Tachycardia/hypertension</li><li><strong>Mydriasis</strong></li></ul></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>Methamphetamine</strong></p></td><td style=\"width:20.84%\"><p align=\"center\">Stimulant</p></td><td style=\"width:49.74%\"><ul><li>Violent behavior</li><li>Psychosis, diaphoresis</li><li>Tachycardia/hypertension</li><li>Choreiform movements</li><li>Tooth decay</li></ul></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>Marijuana</strong></p><p align=\"center\"><strong>(THC, cannabis)</strong></p></td><td style=\"width:20.84%\"><p style=\"text-align: center;\">Cannabinoid</p></td><td style=\"width:49.74%\"><ul><li>Increased appetite</li><li>Euphoria</li><li>Dysphoria/panic</li><li>Slow reflexes, impaired time perception</li><li>Dry mouth</li><li><strong>Conjunctival injection</strong></li></ul></td></tr><tr><td style=\"width:29.42%\"><p align=\"center\"><strong>Heroin</strong></p></td><td style=\"width:20.84%\"><p align=\"center\">Opioid</p></td><td style=\"width:49.74%\"><ul><li>Euphoria</li><li><strong>Depressed mental status</strong></li><li><strong>Miosis</strong></li><li><strong>Respiratory depression</strong></li><li>Constipation</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:100.0%\"><strong>PCP</strong> = phencyclidine; <strong>THC </strong>= tetrahydrocannabinol.</td></tr></tbody></table></div><p>This patient&#39;s presentation is most consistent with <strong>cannabis (marijuana) intoxication</strong>.&nbsp; The primary psychoactive chemical in cannabis is delta-9-tetrahydrocannabinol (THC), which can produce effects within minutes if inhaled or after a few hours if ingested.&nbsp; With the advent of high-potency cannabis formulations (eg, edibles, concentrates), unintentional ingestion of high doses of THC is becoming more common.</p><p>Physiologic effects include <strong>conjunctival injection (red eyes)</strong>, <strong>dry mouth</strong>, <strong>tachycardia</strong>, and increased appetite.&nbsp; Cognitive effects include <strong>slow reaction time</strong>, incoordination, impaired short-term memory, and poor concentration.&nbsp; Some individuals may experience dysphoria, social withdrawal, <strong>anxiety</strong>, and <strong>paranoia</strong> when exposed to higher doses of THC.&nbsp; <strong>Psychomotor impairment</strong> lasts beyond the timeframe of euphoria and can persist for up to a day.</p><p><strong>(Choice A)</strong>&nbsp; Bath salts (synthetic amphetamine analogues) intoxication presents with tachycardia, hypertension, mydriasis, agitation, and violent behavior at higher doses.</p><p><strong>(Choice C)</strong>&nbsp; Cocaine intoxication can also cause anxiety, paranoia, and tachycardia, but it is associated with pupillary dilation, not conjunctival injection, as well as diaphoresis.</p><p><strong>(Choice D)</strong>&nbsp; Cocaine withdrawal typically presents with dysphoria, difficulty concentrating, and increased sleep and appetite, as well as depression and possible suicidality.&nbsp; It does not cause the dry mouth and conjunctival injection seen with cannabis use.</p><p><strong>(Choice E)</strong>&nbsp; Lysergic acid diethylamide (LSD) intoxication presents with tachycardia, hypertension, visual hallucinations, and paranoia at higher doses.</p><p><strong>(Choice F)</strong>&nbsp; Opioid intoxication is characterized by the triad of respiratory depression, pinpoint pupils, and central nervous system depression.&nbsp; Other features include hypotension, hypothermia, and bradycardia, none of which are seen in this patient.</p><p><strong>(Choice G)</strong>&nbsp; Opioid withdrawal is characterized by lacrimation, pupillary dilation, yawning, diaphoresis, and gastrointestinal symptoms (eg, nausea, vomiting, diarrhea).</p><p><strong>(Choice H)</strong>&nbsp; Phencyclidine intoxication typically presents with nystagmus and ataxia.&nbsp; Although patients may experience psychosis, they usually have associated violent behavior, agitation, and dissociation.</p><p><strong>Educational objective:</strong><br>Patients with cannabis intoxication typically present with conjunctival injection, dry mouth, tachycardia, and increased appetite.&nbsp; Psychomotor impairment, anxiety, and paranoia may also occur, especially at higher doses.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 23711,
            "topic": "Cannabis",
            "titleId": 23711,
            "title": "Cannabis",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bath salts intoxication",
                    "choiceNumber": 1,
                    "correctTaken": 485,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cannabis intoxication",
                    "choiceNumber": 2,
                    "correctTaken": 13011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cocaine intoxication",
                    "choiceNumber": 3,
                    "correctTaken": 1474,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cocaine withdrawal",
                    "choiceNumber": 4,
                    "correctTaken": 174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lysergic acid diethylamide intoxication",
                    "choiceNumber": 5,
                    "correctTaken": 650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opioid intoxication",
                    "choiceNumber": 6,
                    "correctTaken": 885,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opioid withdrawal",
                    "choiceNumber": 7,
                    "correctTaken": 884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phencyclidine intoxication",
                    "choiceNumber": 8,
                    "correctTaken": 285,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1458,1579,true,-1,1*629,668,true,-1,1*1344,1390,true,-1,1*987,1079,true,-1,1*1787,1847,true,-1,1*1958,1976,true,-1,1*280,295,true,-1,1*613,628,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25987916",
                    "mediaDataId": 0,
                    "title": "Psychiatric and medical management of marijuana intoxication in the emergency department.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25987916",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26878835",
                    "mediaDataId": 0,
                    "title": "The effects of cannabis intoxication on motor vehicle collision revisited and revised.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26878835",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 17848,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 844,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 3535,
            "questionIndex": 3535,
            "questionText": "<p>A long-time patient comes to the office for a routine physical examination accompanied by his wife.&nbsp; He has a history of hypertension, obesity, and osteoarthritis.&nbsp; At the last visit, the physician recommended an exercise and weight loss regimen to improve his condition.&nbsp; The patient subsequently cancelled his next 2 appointments, explaining that things came up at the last minute.&nbsp; At today&#39;s visit, the patient reports low energy and pain in his knees, back, and hands.&nbsp; His wife is worried that he is not doing well.&nbsp; Blood pressure is 150/90 mm Hg, pulse is 84/min, and respirations are 18/min.&nbsp; Examination shows a 3.18-kg (7-lb) weight gain and decreased range of motion.&nbsp; During the visit, the patient shows a detailed understanding of his illnesses and readily acknowledges the importance of medication, diet, and exercise.&nbsp; However, he admits that he has a hard time dieting, has not exercised because it hurts his knees, and sometimes forgets to take his antihypertensive medications.&nbsp; Which of the following is the best initial response to address this patient&#39;s nonadherence to treatment?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Nonadherence</strong> is a common cause of poor medical outcomes.&nbsp; This patient is having difficulty adhering to his medication regimen and recommendations for diet and exercise.&nbsp; Reasons for poor adherence are often complex and include inadequate understanding of the illness, complicated regimens, medication cost, side effects, illness perceptions, treatment beliefs, and psychological factors (eg, depression, anxiety, hopelessness, cognitive impairment, denial).&nbsp; This patient appears to have an adequate understanding of his illness and treatment, but other causes are not clear.&nbsp; His repeated cancellations may reflect his desire to avoid his medical issues and/or his fear of the physician&#39;s disapproval.</p><p>The best initial approach is to <strong>empathize</strong> with the patient&#39;s difficulty and engage him in an <strong>open-ended discussion</strong>.&nbsp; The physician should strive to create an environment in which the patient feels comfortable discussing personal issues and difficulties that may be interfering with adherence.&nbsp; Communications that are empathic, <strong>patient-centered</strong>, and <strong>nonjudgmental</strong> will have the best chance of building rapport and engaging this patient in collaborative treatment planning.</p><p><strong>(Choices A, E, and F)</strong>&nbsp; Although further efforts to educate the patient about his condition and treatment or reinforcing the importance of daily medication adherence may be helpful, the first step is to build a treatment alliance so the patient does not feel judged.</p><p><strong>(Choices B and C)</strong>&nbsp; Although these statements convey concern, they may be perceived as critical or condescending.</p><p><strong>Educational objective:</strong><br>Physicians should explore nonadherence in an empathic and nonjudgmental manner and try to understand behavior from the patient&#39;s perspective.&nbsp; This will help build rapport and facilitate development of a united plan.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 23754,
            "topic": "Treatment adherence",
            "titleId": 23754,
            "title": "Treatment adherence",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Although you don&#39;t feel the effects of high blood pressure, it is important to take your medication every day.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I am concerned that your diet and lack of exercise are making your conditions worse.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I can understand why your wife is worried about your health.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It can be difficult to keep up with diet, exercise, and medication on a daily basis.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 12986,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Let me explain how diet and exercise can help you feel better.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Let me provide written medication instructions and we can go over them in detail.&#x22;",
                    "choiceNumber": 6,
                    "correctTaken": 665,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20528525",
                    "mediaDataId": 0,
                    "title": "Strategies to improve adherence with medications in chronic, &#39;silent&#39; diseases representing high  cardiovascular risk.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20528525",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19584762",
                    "mediaDataId": 0,
                    "title": "Physician communication and patient adherence to treatment: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19584762",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 325,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 15297,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 379,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 12328,
            "questionIndex": 13547,
            "questionText": "<p>A 59-year-old woman comes to the office to follow up for chronic back pain caused by a motor vehicle collision.&nbsp; A month ago, the patient was given scheduled-dose oral morphine.&nbsp; Her pain level has decreased from 8 to 3 on a scale of 0-10, and pain no longer interferes with activities of daily living.&nbsp; There has been no drowsiness, constipation, or nausea.&nbsp; Other medications include naproxen, acetaminophen, and a lidocaine patch as needed.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 114/76 mm Hg, pulse is 64/min, and respirations are 12/min.&nbsp; On examination, the back has greater range of motion than it did during the last visit.&nbsp; Which of the following would be most helpful in the early detection of prescription opioid misuse in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T78676\"><table class=\"table-default-style table-header-footer-style\" style=\"width:65.4%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Opioid prescribing best practices</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Prior to<br>initiation</strong></p></td><td style=\"width: 75%;\"><ul><li>Screen for risk factors for misuse</li><li>Perform urine drug screening</li><li>Query PDMP database</li><li>Sign controlled substance agreement (eg, 1 prescriber, 1 pharmacy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>During<br>therapy</strong></p></td><td><ul><li>Follow up every 1-3 months</li><li>Query PDMP database before each refill</li><li>Perform random urine drug screenings</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PDMP</strong> = prescription drug monitoring program.</p></td></tr></tbody></table></div><p>Opioids account for three-quarters of all fatal prescription drug overdoses; early identification of misuse is critical in ensuring patient safety.&nbsp; <strong>Opioid misuse</strong> is defined as taking the medication in a way that deviates from the manner (eg, overuse, diversion) and purpose (eg, relieve anxiety) for which it was prescribed.&nbsp; Obtaining opioids from multiple prescribers, taking nonprescribed opioids, and concurrently using recreational drugs or other nonprescribed controlled substances also constitute misuse.</p><p>The <strong>prescription drug monitoring program (PDMP)</strong> is a helpful tool for detecting misuse.&nbsp; The state-specific PDMP is a record of prescribed controlled substances that the patient has obtained, including the quantities, dates the prescriptions were filled, and prescriber information.&nbsp; The PDMP can identify patients who are receiving opioids from <strong>multiple prescribers</strong>, suggesting possible <strong>overuse</strong> or <strong>diversion</strong>.&nbsp; The database should be queried before each refill to help ensure appropriate use.</p><p><strong>(Choices A and B)</strong>&nbsp; Functional capacity (eg, range of motion) and pain level should be assessed at each visit to determine the efficacy of therapy and to guide dose adjustments when necessary.&nbsp; These evaluations do not provide information on misuse.</p><p><strong>(Choice C)</strong>&nbsp; Patient vital signs can demonstrate evidence of acute opioid intoxication (eg, bradypnea, bradycardia, hypotension) but would not indicate misuse without acute intoxication.</p><p><strong>(Choice D)</strong>&nbsp; Urine drug screenings can identify diversion (eg, test is negative for opioids), recreational drug use, and concurrent use of other controlled substances undivulged by the patient.&nbsp; However, they are best done randomly because scheduled screenings can lead to patient preparation that would misrepresent screening results.</p><p><strong>Educational objective:</strong><br>The prescription drug monitoring program records prescribed controlled substances that the patient received, including quantities, dates the prescriptions were filled, and prescriber information.&nbsp; This database can identify patients who are obtaining opioids from multiple prescribers, thereby raising concern for overuse or diversion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24720,
            "topic": "Prescription drug misuse",
            "titleId": 24720,
            "title": "Prescription drug misuse",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Assessing back range of motion at each visit",
                    "choiceNumber": 1,
                    "correctTaken": 594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Assessing pain level at each visit",
                    "choiceNumber": 2,
                    "correctTaken": 1680,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monitoring vital signs at each visit",
                    "choiceNumber": 3,
                    "correctTaken": 1439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtaining a scheduled urine drug screening at each visit",
                    "choiceNumber": 4,
                    "correctTaken": 2535,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Querying the prescription drug monitoring database at each visit",
                    "choiceNumber": 5,
                    "correctTaken": 12624,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1849,2173,true,-1,1*119,147,true,-1,1*168,234,true,-1,1*259,276,true,-1,1*323,352,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28152391",
                    "mediaDataId": 0,
                    "title": "Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey of Drug Use and Health.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28152391",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28498498",
                    "mediaDataId": 0,
                    "title": "Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 U.S. states.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28498498",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 18872,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 555,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 11385,
            "questionIndex": 12541,
            "questionText": "<p>A 42-year-old man comes to the office for a follow-up.&nbsp; He has a history of gastroesophageal reflux disease, hypertension, and alcohol use disorder.&nbsp; Last year, the patient was hospitalized for acute gastritis.&nbsp; During the hospitalization, he went into alcohol withdrawal that was treated with chlordiazepoxide.&nbsp; The patient was abstinent for 2 weeks following discharge but then started drinking 2 or 3 beers several times a week.&nbsp; Over the past several months, he has been drinking 6-10 beers daily.&nbsp; The patient says, &#x22;I want to cut down, but the cravings are too strong.&#x22;&nbsp; He fears he will lose his job and family if he continues to drink.&nbsp; He has had a history of alcohol abuse since age 14 and has smoked 1.5 packs of cigarettes daily for the past 12 years.&nbsp; The patient does not use illicit drugs.&nbsp; There is a family history of alcohol abuse in his mother and heroin abuse in his brother.&nbsp; Vital signs and physical examination are within normal limits.&nbsp; In addition to psychosocial interventions, which of the following is the most appropriate pharmacotherapy for this patient&#39;s alcohol use disorder?</p>",
            "questionHeader": "",
            "explanationText": "<p>Although this patient desires to reduce his alcohol intake, he is unable to control his strong cravings and is drinking increasing amounts.&nbsp; Pharmacotherapy should be considered in patients with moderate to severe <strong>alcohol use disorders</strong>.&nbsp; Medications that target the reinforcing effects of alcohol by modulating opioid and glutamate function are effective.&nbsp; <strong>First-line</strong> treatment options include <strong>naltrexone</strong>, a mu-opioid receptor antagonist, and <strong>acamprosate</strong>, a glutamate modulator.</p><p>Naltrexone has been shown to decrease alcohol craving, reduce heavy drinking days (defined as &gt;5 drinks for men and &gt;4 for women), and increase days of abstinence.&nbsp; It can be initiated while the patient is still drinking.&nbsp; It is contraindicated in patients taking opioids as it can precipitate withdrawal, and in those with acute hepatitis or liver failure.&nbsp; Acamprosate, which is primarily used to maintain abstinence,&nbsp;should be avoided in patients with significant renal impairment.</p><p><strong>(Choices A and F)</strong>&nbsp; Buprenorphine is an opioid partial agonist used in the treatment of opioid use disorder and pain management.&nbsp; Valproate is an anticonvulsant agent used in the treatment of epilepsy and bipolar affective disorder.&nbsp; Neither of these medications is recommended for the treatment of alcohol use disorder.</p><p><strong>(Choices B and G)</strong>&nbsp; Bupropion and varenicline are first-line pharmacologic therapies for smoking cessation, not alcohol use disorder.</p><p><strong>(Choice C)</strong>&nbsp; Benzodiazepines (eg, chlordiazepoxide) are indicated for the treatment of moderate to severe alcohol withdrawal.&nbsp; They do not treat alcohol use disorder and have a high risk of abuse.</p><p><strong>(Choice D)</strong>&nbsp; The aldehyde dehydrogenase inhibitor disulfiram is an aversive agent that causes an unpleasant physiologic reaction (tachycardia, flushed skin, headache, nausea, vomiting) when alcohol is consumed.&nbsp; It can be used only in abstinent patients and would not be preferred in this patient who is actively drinking.&nbsp; Candidates for disulfiram must be highly motivated or take the medication in a supervised setting as a patient may skip a dose to avoid the medication&#39;s aversive reaction when alcohol is desired.&nbsp; It is considered a second-line agent that is used when naltrexone and acamprosate are either ineffective or contraindicated.</p><p><strong>Educational objective:</strong><br>Naltrexone is a first-line pharmacotherapy for alcohol use disorder that decreases craving and heavy drinking.&nbsp; It can be initiated in opioid-free patients without significant liver disease who are still drinking.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24408,
            "topic": "Alcohol use disorder",
            "titleId": 24408,
            "title": "Alcohol use disorder",
            "topicAttributeId": 330674,
            "topicAttribute": "Substance use disorders",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Buprenorphine",
                    "choiceNumber": 1,
                    "correctTaken": 885,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 2,
                    "correctTaken": 759,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chlordiazepoxide",
                    "choiceNumber": 3,
                    "correctTaken": 420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disulfiram",
                    "choiceNumber": 4,
                    "correctTaken": 4278,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Naltrexone",
                    "choiceNumber": 5,
                    "correctTaken": 9952,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Valproate",
                    "choiceNumber": 6,
                    "correctTaken": 57,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Varenicline",
                    "choiceNumber": 7,
                    "correctTaken": 551,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1013,1120,true,-1,1*385,508,true,-1,1*509,993,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27402770",
                    "mediaDataId": 0,
                    "title": "Reductions in alcohol craving following naltrexone treatment for heavy drinking.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27402770",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24825644",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24825644",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 206,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 16902,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 759,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}